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ABSTRACT
Tammy Ying
Rebecca A Simmons
Adipose tissue has multiple functions including defense against the cold through
thermogenesis of brown and beige adipocytes. The type 2 immune cytokine Interleukin-4
(IL-4) can increase beige adipogenesis in mature rodents. However, developing animals
use a distinct adipocyte precursor compartment for adipogenesis compared to adults. In
this body of work, we analyze the effects of IL-4 on the adipose tissue of developing
rodents. In rats, we found that exogenous IL-4 induced an acute increase in beige
adipogenesis and a persistent decrease in overall adipogenesis in neonatal inguinal white
adipose tissue (iWAT). We determined that DPP4+ progenitors and ICAM1+
preadipocytes were the populations expressing IL-4 receptor in neonatal mice. Isolating
neonatal ICAM1+ preadipocytes for RNA-seq, we discovered no significant differentially
regulated genes in IL-4RaKO compared to WT. After adipogenic differentiation of IL4RaKO and WT ICAM1+ preadipocytes, we also found no changes in adipocyte gene
expression. However, using neonatal WT ICAM1+ preadipocytes, we show that IL-4
pretreatment increases Ucp1 expression. We also identified that IL-4 directly interferes
with the process of adipogenesis, decreasing adipocyte maturation. Overall, these
findings describe the role of IL-4 in developing iWAT, identify the precursor population
altered by IL-4 receptor signaling and characterize long term effects of IL-4 that may
influence the later onset of obesity.
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CHAPTER 1: INTRODUCTION
This chapter is adapted from: Ying, T., and R. A. Simmons. 2020. "The Role of
Adipocyte Precursors in Development and Obesity." Front Endocrinol (Lausanne)
11:613606. doi: 10.3389/fendo.2020.613606. (Ying and Simmons 2020)

1.1 Adipose tissue development
Adipose tissue is generally known to be composed of specialized cells that store
lipid as energy (JK and AJ 2007). Once viewed as an inert organ of energy storage,
adipose tissue is now appreciated to be a central node for the dynamic regulation of
systemic metabolism and energy expenditure (Scherer 2006). This is due to the presence
of multiple different types of adipose tissue in mammals: white, beige and brown (Zoico
et al. 2019). Whereas white adipose tissue (WAT) does store lipid, brown adipose tissue
(BAT) and beige adipose tissue participate in thermogenesis and release energy as heat
(CY and A 2008; Seale et al. 2011; Cannon and Nedergaard 2004). These diverse tissues
develop from unique cell lineages at different points during gestation as well as
postnatally (Han et al. 2011). There are a number of critical periods during adipose tissue
development that appear to influence the later onset of obesity, in particular the perinatal
period (Hepler and Gupta 2017). With the advancement in our understanding of
epigenetics, there has been an increasing amount of interest in molecular regulation of
adipogenesis in the developing animal. An indepth understanding of this area could aid in
development of tools to regulate adipogenesis and lead to new clinical applications.
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There are no studies of developmental adipogenesis in the human, thus this
introduction will focus on studies that have been carried out in mice or in human-derived
cell-lines.

White, brown and beige fat
Adipose tissue includes brown, beige and white fat. Whereas white fat stores
energy as lipid, brown fat releases energy as heat. Uncoupling protein 1 (UCP1) is the
critical protein required for this thermogenesis in brown adipocytes. Major and minor fat
depots exist throughout the human and mouse, but the major areas of focus for BAT are
divided into interscapular (mouse) and supraclavicular (human) (Bjørndal et al. 2011).
Interscapular BAT has been shown to derive from the paraxial mesoderm (Atit et al.
2006). Developmentally, cells expressing paired dermomyotomal box protein 7+ (Pax7)
and Engrailed 1 (En1) have been shown to contribute to interscapular BAT (Lepper and
Fan 2010; Atit et al. 2006).
Previously, it was thought that BAT and WAT were two lineages that diverged
developmentally from the same precursor cell type. However, recent evidence suggests
that BAT actually develops from a separate cell population than WAT or beige tissue.
The BAT progenitor population expresses the cell surface marker Myf5+, whereas the
WAT and beige tissue progenitors are platelet-derived growth factor receptor alpha
positive (Pdgrfa+) (Seale et al. 2008; Berry and Rodeheffer 2013). Pdgfra encodes a
tyrosine kinase that marks mesenchymal stromal cells (Gao et al. 2018). Myf5 encodes a
basic-helix-loop-helix transcription factor that initiates the myogenic differentiation
program (Cossu, Tajbakhsh, and Buckingham 1996). Therefore, BAT and muscle cells
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are derived from the same Myf5+ precursor cells and are subsequently interlinked
functionally as well (Kong et al. 2018). WAT and beige precursors derive from the same
Pdgfra+ precursors as fibroblasts, undergoing a completely separate development than
BAT. Because white and brown fat come from these separate cell types, in vivo lineage
tracing must be done using different animal models. This has led to specific work
delineating either BAT precursors or WAT precursors with little comparison between the
two.
Overall, adipocytes typically are derived from the embryonic mesoderm similar to
skeletal muscle, bone and connective tissues. Therefore, progenitors in adipose tissue can
become osteoblasts, myoblasts, etc. The key marker identifying committed preadipocytes
derived from progenitors and other precursors is peroxisome proliferator activated
receptor gamma (Pparg), which is required and sufficient for adipocyte differentiation
(Rosen et al. 1999). In brown fat from rodents, Pparg mRNA expression begins at E15.5
and UCP1 protein expression peaks on P10 (Wang, Gao, et al. 2020; Schulz and Tseng
2013). Although BAT has previously been thought of as homogenous, a recent study
using single cell RNA sequencing identified two distinct populations in BAT: cells with
high and low thermogenesis (Song et al. 2020). Although both populations retain
morphological characteristics of brown adipocytes (abundant mitochondria, multilocular
lipids), the high thermogenesis population expresses high Ucp1 mRNA, and low
thermogenesis expresses low Ucp1 mRNA.

Fat development
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As mentioned above, white fat stores energy as lipid. Beige fat can act like white
fat and store energy as lipid or like brown fat and can release energy as heat. Beige fat
becomes thermogenic through transient expression of UCP1, whereas brown fat stably
maintains UCP1 (Zoico et al. 2019). White fat is found throughout the entire body, but
only specific depots are generally dissected and analyzed from the subcutaneous or intraabdominal/visceral compartments. Wilms tumor 1 (Wt1) is a key regulator of
mesenchymal progenitors during kidney and heart development. Interestingly, Wt1 is
expressed in tissues localized near the visceral fat depots, but not WAT or BAT. Knockin mice expressing tamoxifen-inducible Cre-recombinase driven by Wt1 promoter
activity were crossed with reporter mTmG mice. In the crossed mouse, Tomato is
expressed until Tamoxifen injection, then Wnt1-driven Cre cells will express GFP. This
effectively marks all Wnt1 expressing cells at the time of injection. Chau et al found
Wt1+ cells contributed to visceral WAT, but not subcutaneous WAT or BAT. This
supports a model whereby individual anatomical depots have distinct origins (Chau et al.
2014). This method of temporally restricted lineage tracing in mice shows distinct
mesenchymal lineages for subcutaneous and intra-abdominal white adipose depots,
supporting a model whereby individual anatomical depots have distinct origins (Chau et
al. 2014). The major adipose depots in mice begin development at different timepoints.
Gonadal visceral WAT begins specification postnatally, whereas inguinal subcutaneous
white adipose tissue (iWAT) that is formed by postnatal day 30 (P30) begins
specification at E16.5 (Jiang et al. 2014).
Adiponectin (Adipoq) is the most abundant hormone that is secreted by
adipocytes. It plays a central role in obesity-related diseases. Postnatally, Adipoq mRNA
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expression is only found in mature adipocytes (Hong et al. 2015). Interestingly, the
adipocyte precursors in iWAT begin to express Adipoq mRNA by E18.5. Using Pparg
induced tracing in mice, adipose precursors have been shown to be specified as early as
E10.5 (Jiang et al. 2014). Although BAT and beige fat both perform similar functions,
beige adipocytes only begin differentiating in mice after birth and undergo peak
thermogenesis at P21 when kept at room temperature (Wang et al. 2017). Beige
adipocytes are also highly plastic, and under-nutrition during the lactation period has
been shown to decrease beige adipogenesis in P21 mice (Kozak et al. 2012). However,
this decreased beiging is a transient response and does not affect beige adipogenesis in
adult mice. Cold exposure after birth has also been shown to increasing beige
adipogenesis between P7 and P14 (Wu et al. 2020). This increased beiging is persistent
and does increase beige adipogenesis in adult mice. Altogether, these reports suggest that
neonatal signaling can induce both transient and persistent changes in beige adipogenesis.

1.2 Changes in adipose tissue with age
Most research on the adipocyte has been performed on adult animals because
adipose tissue dysfunction usually coincides with aging. This leads to adult-onset
metabolic disorders, including inflammation and insulin resistance (Palmer and Kirkland
2016). However, there are physiological changes in normal adipose tissue that occur with
age.

Adipocyte expansion
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First, the formation of fat depots in developing animals is a drastically different
process than the accumulation of fat in mature animals. The main difference is in the type
of fat tissue growth. Hypertrophic growth is due to enlargement of individual adipocytes
through lipid deposition (Hepler and Gupta 2017). Hyperplastic growth is a result of
increased cell numbers (adipogenesis). Hyperplastic growth from adipogenesis can
include proliferation of adipocyte precursors and an increased rate of terminal
differentiation into mature adipocytes (Hepler and Gupta 2017).
Neonatal adipose tissue in mice expands through hypertrophy and hyperplasia. In
vivo, the IL-4 receptor signaling pathway has been proposed to be activated in neonates
for adipose precursor proliferation, contributing to hyperplasia (Lee, Odegaard, et al.
2015). Fat tissue in adult females also exhibit hypertrophy and hyperplasia, but adult
male iWAT is almost exclusively expanded through hypertrophy (Wang et al. 2013). This
hypertrophic growth is highly correlated to metabolic disease, garnering increased
interest in developing a method to induce hyperplastic growth and suppress hypertrophic
expansion.

Adipocyte turnover
Adipocyte turnover also changes with age. Thus, it is important to keep in mind
that adipocyte precursors affected by external stimuli in developing animals will become
adipocytes much sooner than adipocyte precursors affected by external stimuli in mature
animals. Because of the adult adipocyte’s slow turnover, stimuli that affects the precursor
population in vitro may not show any significant changes in vivo. In contrast, phenotypes
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seen in vivo due to external stimuli may be due to effects on the mature adipocyte and not
the precursor population.
The process of adipogenesis also has been reported to change with age. The
Gupta/Scherer group found C/ebpa is not required for the maturation of precursors in
iWAT or perigonadal WAT during postnatal development. However, C/ebpa is required
for adult adipogenesis (Wang et al. 2015). The Rodeheffer lab compared adipogenesis in
obese adult animals and adipogenesis in normal neonates, finding that the PI3K-AKT2
pathway is required in expansion of WAT that occurs during obesity, but not in
developmental WAT growth (Jeffery et al. 2015).

1.3 Separation of developmental and adult adipocyte precursors
This review will follow the nomenclature the Graff lab has defined: adipocyte
precursors during the developmental period (E1-P28) are referred to as ‘Developmental’
adipocyte precursors and during the adult period are (P28 onward) referred to as ‘Adult’
adipocyte precursors. They developed an AdipoTrak system, which is a Pparg-reporter
strain that is repressed by Doxycycline. They showed through a time course of
AdipoTrak labeling that adult preadipocytes are specified to their fate earlier than
developmental preadipocytes even though they do not go through terminal differentiation
until after the developmental preadipocytes have all differentiated (Figure 1.1). For
adipose tissue that developed within the first 30 days of life, gonadal precursors began
expressing PPARg between P4 and P10 (Jiang et al. 2014). Subcutaneous precursors
began expressing PPARg between E14.5 and P2. The earliest PPARg+ precursors that
were destined to terminally differentiate between P1 and P30 were identified at E14.5
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(Jiang et al. 2014). PPARg+ precursors that developed into adult fat after P30 are
PPARg+ by E10.5 (Jiang et al. 2014).
The major question the Graff lab asked was whether the developing adipocyte
precursor population changes over time to become the adult adipose precursor population
or if both populations are unique in origin. Using a conditional deletion of Pparg in the
stem compartment that differentiates into adult adipocyte precursors (E0-E10.5), they
found no change in phenotype in neonatal mice, but much leaner adult mice with
metabolic disorder. These results strongly suggest that developing adipose precursor cells
and adult adipose precursor cells are two distinct populations (Jiang et al. 2014).
The adipocyte precursor populations have also been traced in vivo using plateletderived growth factor receptors, PDGFRa and PDGFRb (fibroblast lineage markers).
Through mosaic lineage labeling, it was recently shown that adipocytes formed during
the postnatal period are derived from both these lineages, but adipocytes formed during
adulthood derive only from the Pdgfra lineage (Sun et al. 2020). Deletion of Pdgfra
during the postnatal period increases adipogenesis, but deletion of the same gene during
adulthood enhances beige adipogenesis. Interestingly, deletion of Pdgfrb enhances
overall adipogenesis.
The developmental and adult adipose precursors also localize to different
anatomical niches. One explanation the Graff lab proposes is that this is due to functional
differences in migratory potential of the precursor populations. However, angiogenesis
and tissue resident macrophages are required for normal development of perigonadal
intra-abdominal WAT, suggesting that the micro-environment could also regulate
adipocyte precursors. The adult adipocyte precursors (PPARg+) were found at P30 in
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SMA+ cells in blood vessels. By P60, they had differentiated into mature adipocytes
marked by lipid. Inducible deletion of Pparg in SMA+ cells led to metabolic disorder.
Whereas SMA+ adult adipocyte precursors have been localized through lineage tracing to
the mural perivascular region, neonatal adipocyte precursors have not. The location of
neonatal adipocyte precursors is still unclear.
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Figure 1.1: Developmental and adult adipocyte precursor specification timeline.
Timing of adipogenesis for adult versus developmental adipocyte precursors.
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1.4 The adipose tissue environment
In early studies, adipocyte precursors were identified in the stromal vascular
fraction (SVF) using in vitro culture assays with adipocyte differentiation media selected
against fibroblasts, immune cells, etc. and selected for adipogenic precursors. However,
more recently, in order to ensure cell autonomous effects, researchers have been using
more stringent protocols to isolate adipocyte precursor populations (Cawthorn, Scheller,
and MacDougald 2012). The question is what defines a particular precursor population?
Previous studies used FACs to sort out fibroblasts (CD31+) and immune cells (CD45+)
from the SVF and isolate stem cell antigen positive cells (SCA1+). Further purification of
CD24+ and CD24- isolated stem cell-like progenitors and committed preadipocytes
respectively. However, those two populations are still heterogenous to some extent.
Single-cell RNA sequencing (scRNA-seq) with unsupervised clustering has become the
gold standard for the identification and classification of unique cell populations. Several
labs have used this approach in murine adipose tissue, but mainly in mature animals
(Henriques et al. 2020).

Niche localization
The Deplancke lab was one of the first to perform scRNA-seq on 208 cells from
the SVF of the transgenic mouse DLK1-RFP mouse strain. They used male and female
mature mice and identified CD142+ cells in their single cell analyses. Functional studies
in vitro suggest that they are adipogenesis-regulatory cells (Schwalie et al. 2018). These
results differ from those of the Seale lab, but this could be due to differences in animal
strain and flow sorting strategies. Next, the Granneman lab published scRNA-seq data of
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33,663 cells from mature male C57BL6 mice showing that there is different Pparg
expression in gonadal WAT adipocyte precursors compared to inguinal WAT adipocyte
precursors (Burl et al. 2018).
The Seale lab has published scRNA-seq data on P14 stromal vascular cell
populations in iWAT (Merrick et al. 2019). Combined with pseudo time analysis, this
dataset identified two preadipocyte populations: ICAM1+ and CD142+. These two
originate from the same progenitor, a DPP4+ population. These DPP4+ progenitors are
located in the reticular interstitium, a newly identified niche for adipocyte precursors in
mice. The reticular interstitium is a fluid-filled network of collagen and elastin fibers that
encases adipose depots and other organs (Merrick et al. 2019) (Figure 1.2). The adipocyte
precursors found in this niche express unique lineage markers from those found in the
perivascular compartment. If SMA+ progenitors are responsible for adult adipocyte
precursors, the next goal in this field is to determine whether DPP4+ progenitors are
responsible for developmental adipocyte precursors. These distinct microenvironments
may provide external cues for cellular differentiation and specification in vivo.
Mural SMA+ progenitors, as mentioned above, have also been described as a
precursor to the adult preadipocyte. More pseudo-time analyses will have to be done to
confirm this possible adipose progenitor cell lineage. As mentioned above, adipocytes are
closely related to osteoblasts (bone) and myoblasts (muscle). Therefore, it is not
surprising that adipogenesis occurs within muscle and bone as well. A subpopulation of
multipotent stem cells from bone marrow has recently been identified and is marked by
high expression of Leptin receptor (LepR) (Zhou et al. 2014). LepR mRNA expression
begins postnatally and LepR+ cells are typically quiescent but become active after injury,
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irradiation or transplantation (Gavin et al. 2016). They differentiate into osteoblasts as
well as adipocytes primarily after 2 months of age, suggesting that this population likely
does not contribute to adipogenesis in the developing animal (Yue et al. 2016).
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Figure 1.2: Adipocyte precursor and progenitor niches. Intracellular adhesion
molecular 1 (ICAM1+) cells are committed preadipocytes, which have been localized to
the perivascular space (blood vessels). Dipeptidyl peptidase 4 (DPP4+) cells are
pluripotent progenitor cells that have been localized to the reticular interstitium.
DPP4+ICAM1+ cells are transitioning from DPP4+ to ICAM1+ and located at the
leading edge of the reticular interstitium.

14

Immune cells
Immune cells make up a small percentage of the cells in adipose tissue. They
include eosinophils, innate lymphoid cells (ILCs), T-cells, and macrophages. Recently,
there has been increasing interest in the role of resident macrophages and ILCs in adipose
tissue. Macrophages can be type 1 polarized (M1) as in inflammation, or type 2
polarized (M2) as in allergies. M1 macrophages are responsible for chronic low level
inflammation in adipose tissue. In addition, it has been reported that M2 macrophages
can produce catecholamines, which induce beige adipogenesis (Qiu et al. 2014).
However, this finding has been refuted and there is no current consensus (Fischer et al.
2017).
Innate lymphoid cells (ILCs) are innate counterparts of T cells that contribute to
immune responses by secreting effector cytokines and regulating the functions of other
innate and adaptive immune cells. ILCs are composed of ILC1s, ILC2s and ILC3s. ILC2s
are type 2 polarized, as in allergies, and secrete type 2 cytokines(Panda and Colonna
2019). In adipose tissue, interleukin 33 (IL-33) activates ILC2s, which release type 2
cytokines that promote adipose tissue expansion as well as beige adipogenesis (Lee,
Odegaard, et al. 2015).

1.5 Developmental regulation of adipocyte precursors
Emerging analyses of regulatory mechanisms during perinatal development show
that developmental regulation is distinct from that of mature adipocytes. There are
multiple levels of regulation during adipogenesis, including environmental signals,
transcription factors, RNA splicing, epigenetic modifications, and microRNAs (Figure
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1.3). Environmental signaling changes the chromatin landscape and controls the
expression of adipogenic genes during adipogenesis. Emerging analyses of regulatory
mechanisms during perinatal development show that developmental regulation is distinct
from that of mature adipocytes. Some signals only affect mature adipocytes, while others,
such as the cytokine interleukin-4 (IL-4), only affect adipocyte precursors and not mature
adipocytes due to downsignlaing of the relevant receptor during maturation (Lee,
Odegaard, et al. 2015).
It has been proposed that the IL-4 receptor signaling pathway is activated for
adipose precursor proliferation and WAT development (Lee, Odegaard, et al. 2015).
Many transgenic animal models have been made to study this phenotype in vivo (Table
1.1). IL-4 has also been proposed to inhibit adipogenesis and promote lipolysis through
the upregulation of hormone sensitive lipase (HSL) (Tsao et al. 2014). This pathway is
mainly activated by Il-4 released from eosinophils (Qiu et al. 2014). Although there have
been disparate reports, type 2 immunity has been a popular topic of adipogenesis research
(Lee, Odegaard, et al. 2015; Shiau et al. 2019; Fischer et al. 2017) (Table 1.1). Type 2
immunity is dominant in the newborn and type 2 cytokines are expressed at a much
higher level compared to adults (Basha, Surendran, and Pichichero 2014; Kumar and
Bhat 2016). In addition, ILC2s contribute to type 2 immunity and are divided into 3
populations: fetal, neonatal, and adult (Schneider et al. 2019). Most of the ILC2
population in adipose tissue is neonatally derived and undergoes low replenishment with
adult ILC2s. At the cellular level, IL-4 is reported to increase cAMP, leading to enhanced
PKA activity and phosphosphorylated perilipin. These intracellular changes result in
phosphorylation and translocation of HSL resulting in increased activity.
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Transcription factor regulation of developmental and adult adipocyte precursors is
distinct. In adult obesity models such as high fat diet (HFD), adult adipocyte precursors
require activation through the phosphoinositide 3-kinase (P13K)-AKT2 pathway in order
to differentiate into mature adipocytes (Jeffery et al. 2015). Injection of P13K inhibitors
as well as Pdgfra-cre; Akt2flox/flox mice results in decreased adipogenesis in adulthood
during high fat diet feeding compared to controls (Jeffery et al. 2015). At developmental
timepoints from P0 to P21, Akt2-/- mice have similar rates of adipogenesis compared to
controls. These data suggest that AKT2 phosphorylation is required for adipogenesis in
mature but not developing animals. Another transcription factor, C/EBPA, is also
necessary for adipogenesis of white fat in adult animals, but not homeostatic
adipogenesis during perinatal development. In vivo, C/EBPA targets distinct and seperate
adipogenesis genes compared to PPARg. Defects caused by C/ebpa deletion in adult
WAT can be rescued by overexpression of Adipoq. However, the role of Adipoq in
adipogenesis is as yet unknown. More recently, the Gupta group has shown that the
transcription factor ZFP423 only regulates Pparg in perinatal adipocyte precursors and
not mature adipocytes (Shao et al. 2017). The mechanism of ZFP423 regulation is not
well understood, but these studies support the hypothesis that developmental and adult
adipocyte precursors are unique populations and that they should be studied as two
separate cell types.
UCP1 is temporally regulated by the process of development. Not only is UCP1
protein maximally expressed at P10 in mice, but also splice form regulation of Ucp1
differs between fetal and postnatal development. Splicing does not affect browning but
does affect non-shivering thermogenesis (Odegaard et al. 2017). Odegaard et al have
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shown that this impaired thermoregulation can decrease survival in neonates exposed to
cold. There are 2 Ucp1 splice forms, one that becomes protein and one that has an early
termination codon and does not get translated. Transitioning from gestational to postnatal
life is an environmental challenge that requires activation of thermogenesis to maintain
core temperature. Thus, birth has been reported to trigger an increase in the splice form
that becomes UCP1 protein.
Epigenetic regulation has become a focus of adipocyte biology in recent years. It
has become clear that adipocyte precursor identity and commitment to differentiation is
controlled, at least in part, by epigenetic mechanisms (Margueron, Trojer, and Reinberg
2005) (Figure 1.3). In 3T3-L1 cells, colocalization of C/EBP𝛼 and PPAR𝛾 at enhancers
opens chromatin, which is then enriched with activating histone marks (Lefterova et al.
2008). Although epigenetic regulation of adipose lineage genes has primarily been
studied in adipose cell lines, some new studies are starting to elucidate epigenetic
regulatory mechanisms in primary mammalian cells and in vivo (Matsumura et al. 2015).
Genome-wide analysis of histone modifications using Chromatin
immunoprecipitation combined with sequencing (ChIP-seq) have assessed enrichment of
the histone marks responsible for gene silencing (H3K27me3) and activation (H3K4me3)
in primary mouse adipocyte precursors in neonates and adults (Matsumura et al. 2015).
There is also evidence that this regulation differs between adult and developmental
adipose precursors. Interestingly, at P14 thermogenic genes in iWAT preadipocytes are
enriched for both H3K27me3 and H3K4me3 indicating bivalency which is a hallmark of
stem-cells (Pan et al. 2015). Adult (8 weeks) iWAT adipocyte precursors have lower
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levels of H3K4me3 at these loci, which may partially explain the decrease in adipogenic
potential in adult animals compared to neonates (Pan et al. 2015).
The Ge lab has developed two transgenic mouse lines: one expressing H3.3K36M
(a lysine 36 to methionine mutation on histone H3.3) and one expressing H3.3K4M (a
lysine 4 to methionine mutation on histone H3.3). The transgenic H3.3K36M mutation
blocking H3K36 methylation in early muscle and BAT precursors (Myf5+ cells) showed
impaired muscle and BAT development. Inducing the H3.3K36M mutation in mature
adipocytes (aP2+ cells) did not affect fat development, but impaired thermogenesis in
BAT. They further show that H3.3K36M inhibits adipogenesis by increasing the
silencing marker H3K27me3 at adipocyte lineage genes (Zhuang et al. 2018). For the
transgenic H3.3K4M mutation, the Ge lab show in early muscle and BAT precursors
(Myf5+ cells) that it leads to impaired muscle and BAT development. However, inducing
the H3.3K4M mutation in mature adipocytes (Adipoq+ cells) induced no change in fat
development, maintenance or thermogenesis (Jang et al. 2019). These data suggest that
H3K36 methylation may be required for adipogenesis and thermogenesis, whereas H3K4
methylation is only required for adipogenesis. In the future, crossing these transgenic
mice with conditional reporter mouse strains will delineate the effects of histone
modifications on neonatal adipogenesis and adult adipogenesis.
In adult animals, beige adipocytes express the same gene regulation programs and
posess the same chromatin state as BAT when induced under cold stress. However, in
vivo beige adipocytes revert back to a WAT phenotype with similar WAT gene programs
and chromatin state when under thermoneutrality. Notably, the primed
H3K4me1+/H3K27ac- epigenetic signature at thermogenic gene enhancers such as UCP1
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in these re-warmed adipocytes suggest that they are poised for rapid upregulation of the
thermogenic program (Roh et al. 2018). This correlates with in vivo lineage tracing using
UCP1+ reporter strains. During development, UCP1 peaks postnatally at P21 and then
declines to non-detectable levels at 8 weeks of age. However, cold stress in adult mice
restored the beige phenotype of those same UCP1+ cells that peaked at P21. This
suggests that these cells acquire the epigenetic signature at P21 that is needed to convert
to beige adipocytes during cold stress. Ablation of these cells inhibited cold-induced
beige adipognesis (Wang et al. 2017). However, there was still de novo adipogenesis of
beige adipocytes after 14 days of cold exposure, suggesting that there are 2 waves of
beige adipogenesis during cold exposure and b-adrenergic stimulation.
Another regulatory mechanism of adipogenesis that has been studied recently is
microRNAs (miRNAs). Clinical studies have shown that circulating miRNAs are
dysregulated in obese children (Prats-Puig et al. 2013; Al-Rawaf 2019). However, this
area of adipogenesis research is new and there is limited basic research on neonatal
animals. One interesting in vivo study done in both neonates and adults was on the miR26 family. The miR-26 family of microRNAs are conserved regulators of adipogenesis
and have recently been constitutively deleted using the CRISPR/Cas9 system (Acharya et
al. 2019). Analysis of P10 mice show no change in WAT mass, while adult mice at 5
weeks of age show an increase in whole body fat content (Acharya et al. 2019). This
suggests that miR-26 acts in vivo as a normal suppressor of adult adipogenesis and does
not affect developmental fat. Using this study as an example, further studies on miRNAs
in vivo will need to incorporate neonatal timepoints in order to detect these discrete
phenotypes and gain a complete picture of miRNA regulation.
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Figure 1.3: Regulation of multi-level adipogenesis. Examples of regulatory
mechanisms that control adipogenesis. These mechanisms can be different in
developmental animals compared to adult animals.
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Genotype

Age

WT

p7-12

WT

8
weeks

Tissue
depot
fat

fat
muscle

liver
IL-4/IL-13-/-

8-12
weeks

tibialis
anterior
(TA)
muscles
iWAT

Progenitor
Phenotype
Expresses IL-4Ra
in ICAM1+ and
DPP4+ cells, but
affects CD142+
cells
Expresses IL-4Ra

Tissue
phenotype

Reference
Merrick et al.
2019

Heredia et al.
2013

Does not express
IL-4Ra under
normal or
increased IL-4
conditions
Expresses IL-4Ra
absence of
muscle
regeneration
~56% decrease
in proliferation;
~70% decrease
in numbers
proliferation and
numbers
reduced by
~54% and ~43%;
pSTAT6 reduced
by ~80%

Similar cell size,
decreased
UCP1

Lee et al.
2015

IL-4raf/f
Pdgfr𝛼Cre

5
weeks

iWAT

STAT6-/-

8
weeks

fat

similar cell size, RicardoGonzalez et
decreased
al. 2010
UCP1; DEXA
~60% reduction
in total fat mass

B6C3HF1
(H-2b/k)

42
weeks

fat

loss of dermal
fat tissue

Bigger cell size,
more unilocular
lipid droplets;
decreased
UCP1

Elbe-Burger
et al. 2002

Table 1.1: Wild type and transgenic mouse models of IL-4 in adipose tissue
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1.6 Developmental adipocyte precursors in human health and disease
In humans, adipose depots first appear in the second trimester (Poissonnet, Burdi,
and Garn 1984). Interscapular BAT is found in the first few years of life but decreases
with age (Sidossis and Kajimura 2015). Thermogenic adipocytes are found elsewhere in
the body of adults, but there is much debate over whether they are brown or beige
adipocytes (Chondronikola et al. 2014). New results from single cell RNA sequencing
seems to suggest these thermogenic adipocytes are beige adipocytes (Wu et al. 2012).
Therefore, there has been a wave of studies on brown adipocytes in recent years with the
goal of creating brown adipocytes from human cells which theoretically could be used to
clinically treat obesity through subcutaneous injections.
Another area of adipocyte biology research that could have widespread impact is
the study of individual adipose depots. In humans, obesity caused by the increased mass
of intra-abdominal gonadal WAT (gWAT) is most highly linked to metabolic disease (Gil
et al. 2011). This expansion is usually through hypertrophy, whereas subcutaneous
inguinal WAT (iWAT) in human adults expands predominantly through hyperplasia.
These different depots are currently mainly studied in mouse models. Human and mouse
adipose tissue are similar in that females preferentially accumulate iWAT, while males
preferentially accumulate more gWAT. However, female adult mice may be better
models for the general study of adipogenesis as they expand both iWAT and gWAT,
whereas male adult mice mainly have high levels of adipogenesis in eWAT (Wang et al.
2013). In neonates both males and females undergo hypertrophy and hyperplasia,
showing no overt differences.
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1.7 Overview
As discussed above, the development of adipose tissue is an area that has not been
studied in depth. The major findings in recent years have shown that: 1) developmental
adipocyte precursors develop from a unique and distinct cell lineage than adult adipocyte
precursors. 2) External stimuli and internal transcription factors that govern adipogenesis
in adult animals do not necessarily govern adipogenesis in developing animals. Thus,
these observations have revealed a need to revise our understanding of developing
adipogenesis and separate its regulation and functions from adult adipogenesis. The goal
of my thesis work was to further elucidate the mechanisms regulating developmental
adipogenesis by asking the following questions:
First, does IL-4 induce white fat and beige fat development in the neonate? Does
IL-4 regulation persist? Previous studies have observed that IL-4 is highly correlated to
developmental adipogenesis but have been unable to confirm this directly during the
perinatal period due to a lack of genetic models and difficulty injecting neonatal mice.
Therefore, we have utilized a rat model for IL-4 injections to address this question. We
found that neonatal IL-4 induces beige adipogenesis, but not white adipogenesis. In
addition, we saw a persistent decrease in adipogenic potential after adipocyte precursor
exposure to neonatal IL-4.
Second, which adipocyte precursor population is affected by IL-4? Previous
studies have shown that adipocyte precursors express IL-4 receptor and mature
adipocytes do not. However, there has been no further identification of the precursor
population. We used flow cytometry and transgenic mice in order to confirm that
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ICAM1+ cells are the adipocyte precursor population responding to neonatal IL-4
receptor signaling.
Third, at what stages of adipogenesis does IL-4 receptor signaling induce a
phenotype? Transgenic mice were used to identify changes specifically in preadipocytes
that have or have not been exposed to IL-4 receptor signaling during progenitor to
preadipocyte commitment. In vitro cell cultures were used to test preadipocytes exposure
to IL-4 before and during differentiation.
To summarize, this thesis addresses these main questions: 1) Does IL-4 induce
acute and/or persistent white and beige fat development in the neonate? 2) What
adipocyte precursor population is altered by IL-4? 3) At what stages of adipogenesis does
IL-4 receptor signaling induce a phenotype?
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CHAPTER 2: NEONATAL IL-4 EXPOSURE DECREASES
ADIPOGENESIS INTO ADULTHOOD
This chapter is adapted from: Ying, T., T. Golden, L. Cheng, J. Ishibashi, P. Seale, and
R. A. Simmons. 2021. "Neonatal IL-4 exposure decreases adipogenesis of male rats into
adulthood." Am J Physiol Endocrinol Metab 320 (6):E1148-E1157. doi:
10.1152/ajpendo.00600.2020. (Ying et al. 2021)

2.1 Abstract
The cytokine interleukin 4 (IL-4) can increase beige adipogenesis in adult rodents.
However, neonatal animals use a distinct adipocyte precursor compartment for
adipogenesis as compared with adults. In this study, we address whether IL-4 can induce
persistent effects on adipose tissue when administered subcutaneously in the interscapular
region during the neonatal period in Sprague-Dawley rats. We injected IL-4 into neonatal
male rats during postnatal days 1–6, followed by analysis of adipose tissue and adipocyte
precursors at 2 wk and 10 wk of age. Adipocyte precursors were cultured and subjected to
differentiation in vitro. We found that a short and transient IL-4 exposure in neonates
upregulated uncoupling protein 1 (Ucp1) mRNA expression and decreased fat cell size in
subcutaneous white adipose tissue (WAT). Adipocyte precursors from mature rats that
had been treated with IL-4 as neonates displayed a decrease in adiponectin (Adipoq) but
no change in Ucp1 expression, as compared with controls. Thus, neonatal IL-4 induces
acute beige adipogenesis and decreases adipogenic differentiation capacity long term.
Overall, these findings indicate that the neonatal period is critical for adipocyte
development and may influence the later onset of obesity.
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2.2 Introduction
Obesity is a major health problem, affecting nearly a third of the world’s
population (2020). It is tightly linked to type 2 diabetes, heart disease, metabolic
syndrome, and certain cancers (Guh et al. 2009). A chronic imbalance between energy
intake and energy expenditure results in the expansion of adipose tissue, which
characterizes obesity. Once viewed as an inert organ of energy storage, adipose tissue is
now understood to play a central role in regulating systemic metabolism and energy
homeostasis. Adipose tissue comprises energy-storing white adipose tissue (WAT),
thermogenic brown adipose tissue (BAT), and thermogenic beige adipocytes interspersed
within WAT (Ikeda, Maretich, and Kajimura 2018). All three types of adipose tissue
communicate extensively with other organs in the body to maintain energy homeostasis.
WAT adipocytes are histologically characterized by the appearance of a large unilocular
lipid droplet and a low number of mitochondria. WAT is localized in several discrete and
functionally distinct depots. The subcutaneous WAT (represented by inguinal WAT
(iWAT) in rodents) develops first in the fetus, whereas visceral WAT (represented by the
epididymal eWAT in male mice), appears later, at approximately postnatal day 4-5 (P45) (Greenwood and Hirsch 1974). Brown and beige adipocytes are characterized by
multiple small lipid droplets and a high density of mitochondria containing the
uncoupling protein UCP1. Brown and beige adipocytes have received much attention for
their therapeutic potential to augment energy expenditure and thereby combat metabolic
disease (Sidossis and Kajimura 2015).
Thermogenically-competent beige adipocytes develop in WAT depots in response
to various stimuli, including cold exposure. Beige adipocytes can arise from adipocyte
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precursors in WAT through de novo differentiation or through the direct conversion of
mature adipocytes. The b-adrenergic signaling system plays a key role in cold-induced
beige fat biogenesis. Several studies have also implicated a role for type 2 innate immune
signaling in beige fat development in adult animals (Lee, Odegaard, et al. 2015; Rao et al.
2014; Lizcano et al. 2017). However, it is unknown if type 2 innate immune signaling
regulates adipocyte formation during the prenatal and early postnatal period, when there
are high levels of adipogenesis and type 2 immunity (Hepler, Vishvanath, and Gupta
2017; Mohr and Siegrist 2016).
Interleukin-4 (IL-4) and interleukin-13 (IL-13) are type 2 immune cytokines that
are present at higher levels in neonates compared to adults (Qiu et al. 2014). The IL-4
receptor (IL-4R), which can be activated by both IL-4 and IL-13, is highly expressed in
adipocyte precursors, but not in mature adipocytes (Deng et al. 2000). The numbers and
proliferative activity of adipocyte precursors are decreased in young IL-4/IL-13-/- mice
(Lee, Odegaard, et al. 2015). Conversely, IL-4 treatment of adipocyte precursors from
adult mice increases proliferation. These data suggest that IL-4 may regulate adipose
tissue growth during early postnatal development.
In the current study, we made the novel observation that a short and transient IL-4
exposure in neonatal rats decreased adiposity into adulthood. This process was associated
with an acute induction of beige adipogenesis, including the upregulation of Ucp1.
Concurrently, adipocyte precursors’ differentiation capacity is persistently decreased.

2.3 Results
IL-4 treatment of neonatal rats decreases iWAT
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We treated rats with IL-4 daily from postnatal day 1 through 6 (P1-6) to
investigate the effects on adipose tissue (Figure 1A). Our previous studies demonstrate
that perturbations during this early postnatal period cause persistent changes in adult
metabolic health (Stoffers et al. 2003; Pinney et al. 2011; Jaeckle Santos et al. 2014). We
used the two lowest doses of IL-4 that were previously exert effects on adipogenesis in
adult mice: 50ng and 100ng (Ricardo-Gonzalez et al. 2010; MJ et al. 1997). Pups treated
with both doses of IL-4 and control pups gained the same amount of weight during the
treatment period (Figure 2.1B), demonstrating that IL-4 had no overt effects on food
intake or general health. Approximately 5 minutes after the first injection of IL-4, there
was a dramatic rise in serum IL-4 levels (Figure 2.1C). Because IL-4 has a short half-life
in circulation (minutes), we did not assess additional time-points. Gene expression
analysis showed that IL-4R𝛼 expression was enriched in the stromal vascular cell (SVC)
fraction, containing adipocyte precursor cells, as compared to whole iWAT (Figure
2.1D). By P14, animals treated with 50 ng of IL-4 weighed the same as controls whereas
animals treated with 100 ng of IL-4 weighed significantly less (Figure 2A). In addition, a
nested ANOVA of fat mass data from DEXA scans showed that there is significant
variation among treatments and control (F(2,6)=6.865, p-value=0.0281), but not among
litters (p-value=0.3165). Therefore, moving forward we focused on animals injected with
100 ng IL-4 and litter was excluded as a variable. DEXA scans showed that 100ng IL-4
decreased both fat (~0.6g) and lean mass (Figure 2B, 2C). These animals also showed no
change in insulin secretion compared to control (Supplemental Figure 2.1). Further
dissection of the adipose tissue depots revealed that IL-4 significantly decreased the
weight of iWAT (~0.2g), but not BAT or eWAT (Figure 2D). This decrease in iWAT
does not account for the entire decrease in fat as quantified by DEXA. The rest of the fat
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decrease is likely spread throughout the entire animal, including eWAT and BAT, but we
do not have the power needed to detect these small changes. Thus, we focused further
experiments only on iWAT.
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B

P1-6 daily
injections

P14 analyses

10 week
analyses

C

D

Figure 2.1: Exogenous IL-4 had no overt effects on neonatal feeding or growth. A)
Experimental design: Injection during P1-6 of PBS, 50ng IL-4 or 100ng IL-4. Analyses
performed at P14 and 10 weeks of age. B) Weights for animals throughout injection
period and before tissue collection (n=14). C) IL-4 concentration in serum on day 1 of
injections (n=12). D) IL-4 receptor mRNA levels in inguinal white adipose tissue
(iWAT) and stromal vascular cells (SVC) where adipocyte precursors reside (n=3-5).
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D

Figure 2.2: IL-4 decreases iWAT in neonates. A) IL-4 decreases weight of 100ng IL-4
injected cohort, but not 50ng injected cohort, compared to PBS at P14 (n=9). B) DEXA
scan shows IL-4 injected cohort has decreased fat mass compared to PBS control at P14
(n=9). C) IL-4 injected cohort also shows decreased lean mass compared to PBS control
at P14 (n=9). D) Weight is decreased in iWAT and not in other depots at P14 (n=5).
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Supplemental Figure 2.1: IL-4 does not affect insulin secretion from the P14 rat
pancreas. A) Glucose stimulated insulin secretion of islets from 100 ng injected and PBS
injected animals. B) Step-wise perifusion of islets from 100 ng injected and PBS injected
animals.
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IL-4 increases beige adipogenesis acutely in neonatal iWAT
Beige adipose tissue can dissipate energy and suppress weight gain. We thus
considered whether IL-4 decreased iWAT mass by increasing beige adipogenesis.
Histological examination of iWAT in control P14 animals revealed only unilocular lipid
droplets (Figure 2.3A). BAT adipocytes displayed a multilocular morphology and eWAT
adipocytes displayed a unilocular lipid morphology (Supplemental Figure 2.2). In
contrast, analysis of iWAT sections from the IL-4 injected cohort revealed significantly
smaller adipocyte size compared to controls (Figure 2.3A). Ki67 staining showed that
neonatal IL-4 significantly increased the percentage of proliferating cells in iWAT at P14
(Figure 2.3A). Next, we looked at gene expression using qRT-PCR and verified the
efficiency of each primer. Ucp1 mRNA levels were markedly increased in the iWAT of
IL-4 treated animals, while Prdm16 showed no changes (Figure 2.3B). IL-4 treatment
also increased the expression levels of the adipogenic regulator Pparg, an early marker of
adipogenesis and decreased the expression levels of white vs. beige fat-enriched marker
genes Adipoq and Lep in iWAT (Figure 2.3C-D). Retn, another white fat enriched gene
showed no change (Figure 2.3C) Altogether, these results suggest that IL-4 exposure in
the early postnatal period directs adipocyte precursors toward the beige vs. white fat fate.
Although early IL-4 does not increase Prdm16 mRNA expression, even beige
adipogenesis induced by cold is not associated with a higher level of Prdm16 (Waldén et
al. 2012). Although Prdm16 is required for beige differentiation, it is not increased
Prdm16 expression that determines beige adipogenesis.
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Figure 2.3: IL-4 increases beige adipogenesis in neonatal iWAT. A) Representative
images of Hemotoxin and Eosin and Ki67 staining of P14 iWAT 5um histology sections.
These images were taken at 20x magnification and show the morphology of iWAT at P14
in PBS and IL-4 injected cohorts and BAT at P14 in PBS injected cohort. Ki67 area %
quantified and identified with arrows. B) qRT-PCR analysis shows the relative expression
levels of beige adipocyte genes (Ucp1 and Prdm16) in P14 iWAT (n=3-6), C) white
adipocyte genes (Retn and Lep) in P14 iWAT (n=4-5), and D) adipogenesis genes (Adipoq
and Pparg) in P14 iWAT (n=5-6).
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IL-4

eWAT

BAT

PBS

Supplemental Figure 2.2: BAT adipocytes display a multilocular lipid morphology
and eWAT adipocytes displayed a unilocular lipid morphology. Representative
images of BAT, iWAT and eWAT from 2 weeks animals after neonatal injections with
either IL-4 or PBS control.
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Supplemental Figure 2.3: Efficiency curves of Taqman rat primers
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IL-4 increases proliferation of ICAM1 population.
We next sought to separate the effects of IL-4 directly on the neonatal adipocyte
precursor and the effects of IL-4 on the differentiation process of adipogenesis. To test
the former, SVCs were isolated from the iWAT of control P3 animals, plated in culture to
enrich for adipocyte precursors, and incubated with either 10 nM IL-4 or PBS (as control)
for 48 hours. Images taken after 48 hours of IL-4 or PBS incubation show similar
adipocyte precursor morphology (Figure 2.5A). IL-4 treatment significantly increased
cell numbers compared to PBS treatment (Figure 2.5B). The expression of select beige fat
marker genes was quantified in these cultures, revealing that IL-4 augmented the levels of
Tmem26 mRNA but did not affect Klhl13 or Tnfrsf9 levels (Figure 2.5C). Inguinal WAT
SVCs were also isolated from P7 neonates that had been injected with either PBS or IL-4
for 6 days for flow cytometry analysis. ICAM1 was used as an adipocyte precursor maker
because it is the only one that has been shown to define the preadipocyte population in
neonatal rodents (Merrick et al. 2019). IL-4 injected animals had a significant increase in
ICAM1+ cells compared to PBS injected controls (Figure 2.5D). (Supplemental Fig. S4
(https://figshare.com/s/0af6ba98fcddaf43580d)). Therefore, these data suggest that IL-4
increases the proliferation of the ICAM1+ adipocyte precursors.
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Figure 2.4: IL-4 increases proliferation of ICAM1 population. A) Representative
images of adipocyte precursors after exposure to IL-4 for 48 hours. B) Cells were plated
equally in pairs, counted after incubation using a hemocytometer and fold change was
calculated. (n=8). C) qRT-PCR analysis shows the expression level of beige adipocyte
lineage genes: Klhl13, Tmem26 and Tnfrsf9 (n=3). D) Percentage of ICAM1+
preadipocytes by flow cytometry after IL-4 injections (n=3).
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Supplemental Figure 2.4: Flow cytometry gating strategy for ICAM1+ cells. Cells
were first gated by size and then for singlets. Next, DAPI staining was used to gate for
live cells. Then, the CD45- population was selected to gate out immune cells. ICAM1+
cell % was then calculated from this singlet LIVE+ CD45- population.
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IL-4 treatment of mature adipocytes activates Ucp1 expression.
We then tested in vitro whether IL-4 affects the adipocyte differentiation process.
Our goal was to determine the following: 1) The effect of IL-4 pretreatment on adipocyte
differentiation; 2) The effect of IL-4 regulation during either phase of adipocyte
differentiation (multi clonal expansion (MCE) and terminal differentiation); 3) The effect
of IL-4 throughout pretreatment and differentiation. SVCs from P3 rats were plated at
confluency and pretreated for 2 days before incubation with a complete adipocyte
differentiation cocktail for an additional 6 days. IL-4 was added in the following
treatment conditions: 1) Pre-treatment for 2 days before inducing adipocyte
differentiation; 2) During MCE for 2 days; 3) During terminal differentiation for 2 days
(Figure 2.5A) (Supplemental Figure 2.5). IL-4 exposure at various timepoints led to a
decrease in the development of lipid droplet containing adipocytes (Figure 2.5B). The
expression levels of the mature adipocyte marker Adipoq was also dramatically reduced
in IL-4-treated cultures (Figure 2.5C). Chronic IL-4 treatment throughout differentiation
caused the most significant decrease in Adipoq expression. Notably, IL-4 increased Ucp1
levels only when added during terminal differentiation (Figure 2.5D). When IL-4 was
continually added during days 2-6 (IL-4 throughout) there was still a significant increase
in Ucp1 mRNA expression compared to PBS control, but it is likely driven by the IL-4
added during terminal differentiation. Collectively, these data indicate that IL-4 is
sufficient to decrease overall adipogenesis, as well as induce beige fat programming of
adipogenic precursor cells under in vitro conditions.
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Figure 2.5: IL-4 decreases adipocyte maturation in vitro. A) Scheme for experimental
method shows the different IL-4 exposure periods of cells during differentiation
(Pretreatment, IL-4 treatment from day 2-4; MCE, IL-4 treatment from day 4-6; Terminal
differentiation, IL-4 treatment from day 6-8; Throughout, IL-4 treatment from day 2-8).
B) Representative images of adipocyte precursors after differentiation in all treatment
conditions. C) qRT-PCR analysis of Adipoq mRNA expression after IL-4 added during
pretreatment (n=5), MCE (n=4), terminal differentiation (n=4), and throughout
pretreatment and differentiation (n=4). D) qRT-PCR analysis of Ucp1 mRNA expression
after IL-4 added during pretreatment (n=5), MCE (n=4), terminal differentiation (n=4)
and throughout pretreatment and differentiation (n=4).
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Supplemental Figure 2.5: Representative images of stromal vascular cell fraction
from P3 rats before and after adipogenic differentiation.
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Capacity for adipogenesis is persistently decreased in adipocyte precursors after neonatal
IL-4
To determine if IL-4 treatment of neonates induces long lasting effects on adipose
tissue and metabolic phenotypes, we followed a subset of IL-4 treated and control
animals for 10 weeks. Although IL-4 treated animals had decreased body weight
compared to controls at 2 weeks of age, body weight was normalized by 10 weeks
(Figure 2.6A). Fasting glucose of IL-4 treated animals were also decreased at 10 weeks of
age compared to PBS controls (Supplemental Figure 2.6). Dissection of individual fat
depots revealed that the iWAT depot weighed significantly less in treated adult animals
as compared to controls (Figure 2.6B). Histological staining of the iWAT depot show that
10 week control adipocytes are similar to those of IL-4 treated animals in size,
proliferation, and beige adipogenesis (Figure 2.6C). Analysis of pancreatic islets using
perifusion also showed no change in basal and glucose stimulated insulin secretion in IL4 treated cohort compared to PBS controls (Supplemental Figure 2.6).
Because there was a significant decrease in iWAT depot weight between control
and IL-4 treated adult animals that did not correlate with adipocyte morphology, we
analyzed SVCs from the adult animals. SVCs were isolated from 10-week-old rats
previously treated with IL-4 and control (as newborns). SVCs from IL-4 treated rats
displayed a reduced capacity for adipocyte differentiation as reflected by diminished
expression of Adipoq and Pparg mRNA expression in day 8 cultures (Figure 2.6D). There
was no difference in Ucp1 or Prdm16 expression between differentiated cultures from
control and IL-4 treated rats. (Figure 2.6E). These results suggest that beige adipocytes
induced by neonatal IL-4 exposure were not maintained into adulthood.
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Figure 2.6: Capacity for adipogenesis is persistently decreased in adipocyte
precursors after neonatal IL-4.
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A) Whole body weight was measured at 10 weeks of age (n=4). B) iWAT has decreased
weight at 10 weeks of age in IL-4 injected cohort (n=6-7). C) Representative images of
H&E and Ki67 stained iWAT from treatment and control rats at 10 weeks of age. Ki67
area % quantified and identified with arrows. D) qRT-PCR of adipogenesis genes
(Adipoq and Pparg) (n=7) and E) beige adipocyte genes (Ucp1 and Prdm16) from
differentiated SVCs originating in adult control or treatment rats (n=6).
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Supplemental Figure 2.6: IL-4 decreases fasting blood glucose but does not affect
insulin secretion in the adult rat. A) Fasting blood glucose measured from tail vein
after 6 hour fast. B) Perifusion with glucose from 0-25mM of islets from either IL-4
injected animals or controls.
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2.4 Discussion
Although mature adipose tissue has been thoroughly investigated, there are few
studies describing adipogenesis in the developing animal (Merrick et al. 2019).
Therefore, in this study we aimed to determine the immediate- and long-term effects of
the cytokine IL-4 in neonates. First, we made the novel observation that low-dose
exposure of IL-4 during the first week of life significantly decreases body fat and lean
mass by P14. We also observed increased adipocyte proliferation, and decreased
adipocyte size in juvenile animals. Transgenic expression of IL-4 induced a similar
adipose tissue phenotype in older mice (Elbe-Bürger et al. 2002). Several studies have
reported that small adipocytes are especially important for counteracting obesityassociated metabolic decline and have shown that small adipocytes are often correlated
with decreased susceptibility to developing diabetes (Lönn et al. 2010; Lundgren et al.
2007). But these studies were done in adult animals, and it is not clear if size of neonatal
adipocytes correlates with improved glucose homeostasis. Interestingly, the cell size and
proliferation rates do not persist and are similar in adulthood between IL-4 treated
animals and controls. Yet remarkably IL-4 treatment during the neonatal period decreases
iWAT mass in juveniles which persists into adulthood accompanied by improved glucose
homeostasis.
Previous studies have demonstrated that type 2 cytokines, including IL-4, play a
fundamental role in beige fat development in adult rodents (14). However, neonates
utilize a different adipocyte precursor population than adults (Jiang et al. 2014; Schwalie
et al. 2018; Jeffery et al. 2015). This is supported by Hong et al, who first demonstrated
that fetal and neonatal adipose precursors are functionally different from adult adipose
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precursors (Hong et al. 2015). In addition, Wang et al reported that C/EBPα is not
required for the development of WAT in the perinatal period nor development of beige
adipose tissue in the adult, but is required for the maturation of WAT in adulthood (Wang
et al. 2015). In this study, we show that in vivo IL-4 treatment decreases iWAT weight.
eWAT showed no change in weight, potentially explained by its late development at P5
with only 2 full days of exposure to IL-4. Additionally, epididymal adipose tissue is
much less prone to beige adipocyte development. We discovered that IL-4 increased
Ucp1 mRNA expression in neonatal adipocyte precursors only in vivo, but not in vitro.
One explanation could be that IL-4 effects in vivo include indirect signaling through
immune cells such as macrophages and T-cells, which are selected against in adipogenic
media in vitro. There have even been some reports of immune cells activating beige
adipogenesis separate from the IL-4 signaling pathway (Brestoff et al. 2015). Thus, IL-4
may act through both direct and indirect signaling pathways in vivo, which was not
reconstituted in vitro.
We observed significantly decreased Adipoq and Lep mRNA expression at P14,
suggesting that exogenous IL-4 decreases the proportion of mature white adipocytes. We
further demonstrate that this phenotype persistently alters the adipocyte precursor
compartment and results in decreased iWAT at maturity. This could be due to a decrease
in precursor proliferation or a decrease in maturation. In vitro incubation of the SVC
fraction with IL-4 significantly increased proliferation and decreased adipogenesis. In
addition, the altered adipocyte precursor compartment from mature animals was
differentiated in vitro and adipogenesis was significantly decreased. Altogether, these
data support a model whereby neonatal IL-4 is decreasing maturation. IL-4 could be

49

decreasing maturation by changing the precursor pool to favor proliferation of cells with
lower adipogenic potential. Alternatively, another interpretation is that IL-4 is decreasing
the maturation rate of all precursors. With regards to mechanism, this persistently
decreased capacity for adipogenesis suggests that IL-4 may be altering the epigenetic
regulation in adipocyte precursors. Adipocyte precursors in neonates have been reported
to contain bivalent chromatin domains to keep adipogenic genes expressed at low levels,
but easily activated (Matsumura et al. 2015). IL-4 could be disrupting the balance of
bivalency towards continued suppression.
Unexpectedly, neonatal IL-4 also led to improved glucose tolerance in adult
animals. This was unusual because decreased adipocyte differentiation has been highly
correlated with inflammatory cytokines and obesity (Coppack 2001). However, there
have been multiple reports of IL-4 administration in adult mice improving glucose
tolerance and decreasing adipogenesis (Ricardo-Gonzalez et al. 2010; Tsao et al. 2014;
Heredia et al. 2013). A potential explanation is that increased levels of type 2 cytokines
are associated with decreased levels of pro-inflammatory cytokines and this imbalance
between th2 and th1 activity is likely to improve insulin action in the adipocyte (Van
Eden et al. 2002). An alternate mechanism could be that exogenous IL-4 is improving
insulin action in other tissues, such as muscle or liver. Because IL-4 is being introduced
at such an early timepoint in tissue development, the later changes in metabolic health
could also be due to those indirect effects. This remains to be determined and we plan in
future experiments to examine IL-4’s effect on adipogenesis in vivo for a more detailed
analysis of how fat tissue can improve metabolism.
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In this study, we performed IL-4 injections because we had previously reported
that administration of IL-4 cytokine neutralizing antibody to normal or IUGR rats during
the neonatal period induced no change in body fat percentage at 2 weeks of age (Jaeckle
Santos et al. 2014). These data suggested that IL-4 is not required for fat development in
normal newborn animals. This could be because IL-4 levels are not high enough to
induce an observable change in fat development. However, it could not be ruled out that
other factors, such as IL-13, could be compensating as IL-13 signals through the same
receptor as IL-4. Therefore, we injected exogenous IL-4 during the neonatal period to
determine whether it was sufficient to affect developmental adipogenesis. As we have
reported here, neonatal IL-4 is sufficient to induce a persistent decrease in adipogenesis
of adipocyte precursors. In conclusion, adipocyte precursors in the newborn period
respond to IL-4 by acutely increasing beige adipogenesis and persistently reducing fat
mass and improving metabolic parameters. These insights into developmental
adipogenesis may help in developing future therapies for obesity and related diseases.
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CHAPTER 3: IL-4 RECEPTOR SIGNALING INCREASES BEIGING
AND DECREASES ADIPOGENESIS OF ICAM1+ PREADIPOCYTES
This chapter has been adapted from a manuscript that will be submitted to Elife. Ying,
T., Cheng, L., Merrick, D., Seale, P. and R. A. Simmons. " IL-4 Receptor Signaling
Increases Beiging and Decreases Adipogenesis of ICAM1+ Preadipocytes."

3.1 Abstract
The IL-4 cytokine is highly expressed in neonates and has been shown to induce
beige adipogenesis. In this study, we identify the effects of IL-4 receptor signaling in vivo
and in vitro. We phenotyped neonatal WT and IL-4RaKO mice, isolated preadipocytes
for RNA-seq and differentiated preadipocytes in vitro. 2 week old IL-4RaKO mice had
increased total weight and fat mass compared to WT, with a corresponding increase in
expression of white adipocyte genes and decrease in beige adipocyte genes. IL-4Ra
mRNA expression was mainly detected in DPP4+ progenitors and ICAM1+
preadipocytes. ICAM1+ preadipocytes were decreased in neonatal IL-4RaKO compared
to WT but had no significant differentially expressed genes reported by RNA-seq.
ICAM1+ preadipocytes differentiated in vitro and also showed no significant changes in
adipogenesis. Finally, we isolated neonatal WT ICAM1+ preadipocytes for IL-4
pretreatment before in vitro differentiation and IL-4 throughout in vitro differentiation.
Surprisingly, we observed that IL-4 pretreatment before differentiation increases beiging
and IL-4 throughout differentiation decreases maturation compared to WT. Overall, these
findings indicate that IL-4 receptor signaling in WT neonates decreases fat through
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increased beiging, acting directly on ICAM1+ preadipocytes before and during
differentiation.

3.2 Introduction
Adipocyte precursors are a heterogenous population and are critical for regulating
metabolism and the prevention of obesity (Hepler, Vishvanath, and Gupta 2017).
Interestingly, adipocyte precursors encompass a distinct cell type in developing animals
compared to adult animals (Jiang et al. 2014). This may explain the two drastically
different phases of adipogenesis: 1) exponential adipogenesis during the early postnatal
period when actively developing the fat pad; 2) maintenance adipogenesis during
adulthood (Jiang et al. 2014). In this study, we focus on the early postnatal period when
adipogenesis occurs concurrently with changes in the immune system that can potentially
regulate adipogenesis.
Interleukin-4 (IL-4) and interleukin-13 (IL-13) are type 2 immune cytokines that
are present at much higher levels in neonates compared to adults (Qiu et al. 2014). We
and others have found that IL-4 specifically increases adipocyte precursors during the
neonatal and post-weaning period (Ying et al. 2021; Lee, Odegaard, et al. 2015).
However, IL-4 also decreases fat mass in the short term and decreases adipogenic
potential in the long term. IL-4 and IL-13 both signal through the IL-4 receptor, which
requires the expression of IL-4Ra. This receptor is highly expressed in adipocyte
precursors, but not in mature adipocytes (Deng et al. 2000). This suggests that IL-4 could
regulate preadipocyte gene expression as well as interfere with the process of
differentiation up to the final stages of maturation. The numbers and proliferative activity
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of adipocyte precursors are decreased in adult IL-4/IL-13-/- mice (Lee, Odegaard, et al.
2015). Conversely, IL-4 treatment of adipocyte precursors from adult mice increases
proliferation. These data led us to consider whether IL-4 regulates adipose tissue growth
during the early postnatal period.
Here, we sought to further elucidate the mechanisms by which IL-4 acts on
adipogenesis and isolate the effects of IL-4 on the preadipocyte from the effects of IL-4
on the differentiating precursor. Previously, we made the novel observation that a short
and transient IL-4 exposure in neonatal rats decreased adipocyte precursors’ adipogenic
potential and this was maintained into adulthood. In this study, we show that IL-4 both
increases beiging of preadipocytes and directly inhibits the differentiation process to
decrease adipogenesis. These findings are the first to uncouple the direct effects of IL-4
on preadipocytes and on the adipogenesis process.

3.2 Results
IL-4RaKO neonatal mice have decreased fat compared to WT
First, neonatal IL-4RaKO mice were used to determine if IL-4 was required to
maintain normal adipogenesis in developing fat pads in vivo. We characterized IL4RaKO and WT mice at P14 using DEXA scans, which showed that neonates had an
average body weight of ~9 grams and an average body fat mass of ~1.5 grams (Figure
3.1A,B). IL-4RaKO mice weighed significantly more and fat mass was increased
compared to WT controls (Figure 3.1A,B). Leptin and Retn were significantly increased
in iWAT of IL-4RaKO mice compared to WT control (Figure 3.1C). This suggests that
IL-4 in vivo is decreasing white adipogenesis. Correspondingly, IL-4RaKO mice also
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had significantly decreased Ucp1 and Prdm16 expression compared to WT, suggesting
IL-4 in vivo increases beiging (Figure 3.1D).
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Figure 3.1: IL-4RaKO neonatal mice have increased beiging in iWAT compared to
WT. DEXA was used to measure A) Total body weight and B) fat mass of P14 IL4RaKO and WT mice. Gene expression analyses were done on iWAT from P14 IL4RaKO and WT mice. C) White fat genes Lep and Retn and D) beige fat genes Ucp1 and
Prdm16 were measured.
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IL-4RaKO is concentrated in the ICAM1+ preadipocytes and pluripotent DPP4+
progenitors
Next, we sought to determine the cell population that IL-4 is acting on in vivo. IL4Ra mRNA expression in adult mice has been shown to be concentrated in the stromal
vascular cell (SVC) fraction, containing adipocyte precursors, and not in mature
adipocytes (Lee, Odegaard, et al. 2015). Similarly, in neonatal rats, we found that IL-4Ra
mRNA is concentrated in the SVC fraction of inguinal WAT (Ying et al. 2021). Single
cell RNA expression profiling of iWAT of p12 animals revealed that IL-4Ra mRNA
expression was concentrated in the ICAM1+ preadipocytes and DPP4+ progenitor cells
(Figure 3.2A). Moreover, fluorescence activated cell sorting (FACS) analysis showed
that the IL-4Ra protein expression was present on the majority of DPP4+ and ICAM1+
cells (Figure 3.2B).
We quantified ICAM1+ and DPP4+ mesenchymal cells in KO and control iWAT
at P14 by FACS. These mice were on a Balbc background, where WT has a Th2
polarized immune system and high expression of IL-4 (Supplemental Figure 3.1). This
analysis revealed a significant decrease in the number of ICAM1+ preadipocytes in IL4RaKO compared to control iWAT, corresponding well with the increase in ICAM1+
preadipocytes we previously observed in our gain-of-function studies (Ying et al. 2021)
(Figure 3.2C). By contrast, the proportion of DPP4+ progenitors were similar in IL4RaKO and control iWAT (Figure 3.2D, Supplemental Figure 3.2). In addition, we
cultured singlet+LIVE+CD45-ICAM1-DPP4- cells and saw no changes after IL-4
pretreatment and differentiation (Supplemental Figure 3.3A, B). These data support a
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model where DPP4+ progenitors and ICAM1+ preadipocytes express IL-4Ra, allowing
for regulation of fat development through IL-4 receptor signaling.
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Figure 3.2: IL-4Ra is expressed in DPP4+ progenitors and ICAM1+ preadipocytes.
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tSne Plot of IL-4Ra distribution in P12 mice from single cell RNA-seq data (Merrick et
al. 2019). Flow cytometry was used to quantify B) DPP4+ progenitors and C) ICAM1+
preadipocytes in SVC fraction of iWAT from P7-P14 IL-4RaKO and WT mice. D) Flow
cytometry was also used to verify IL-4Ra protein expression on DPP4+ progenitors and
ICAM1+ preadipocytes.
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Supplemental Figure 3.1: Serum IL-4 in Balbc and C57BL6 neonates.
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Supplemental Figure 3.2: Fluorescence activated cell sorting (FACS) strategy for
isolation of ICAM1+ and ICAM1-DPP4- cells
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Supplemental Figure 3.3: ICAM1-DPP4- adipocyte precursors do not respond to
IL-4 pretreatment. A) ICAM1-DPP4- cells pretreated with IL-4 for 48 hours before
differentiation. B) Representative images of cell culture with IL-4 or PBS pretreatment.
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RNA-sequencing shows no differential gene expression between ICAM1+ preadipocytes
in IL-4RaKO compared to WT.
Because a progenitor population (DPP4+) expresses IL-4Ra, we considered
whether exposure to IL-4 receptor signaling during the progenitor to preadipocyte
(ICAM1+) commitment process in vivo might affect the gene expression of ICAM1+
preadipocytes. We performed RNA-sequencing to identify any differentially expressed
genes in IL-4RaKO ICAM1+ preadipocytes compared to WT ICAM1+ preadipocytes.
Surprisingly, there were not statistically significant differentially expressed genes in IL4RaKO ICAM1+ preadipocytes compared to WT ICAM1+ preadipocytes (Table 3.1).
Although our cohort sizes were small, these data suggest that IL-4 receptor signaling
during progenitor to preadipocyte commitment does not affect the ICAM1+ preadipocyte.
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Gene

pvalue

padj

Lrig1
Spns2

log2FoldChange

-4.2291152 0.00034896
-4.4803255 0.00056937

0.99840158
0.99840158

Serpina3g

-4.4809918 0.00057357

0.99840158

Pkdcc

-4.0035832 0.00082115

0.99840158

Adamts17
Hmgcs2

-4.2899961 0.00096667
-3.3184741 0.0009759

0.99840158
0.99840158

Igfbp3

-0.8928203 0.00106247

0.99840158

Gas6

-1.9862555 0.00119201

0.99840158

Gfra2
Mau2

-4.0102448 0.00133076
-4.183498 0.00164076

0.99840158
0.99840158

C3
Col6a5

-3.8326582 0.00211178
-4.0726466 0.00308571

0.99840158
0.99840158

Gja1

1.37706085 0.00319955

0.99840158

Mylk

-2.7609726 0.00362395

0.99840158

Lama2
Mfge8

0.68278925 0.00409776
-2.6304394 0.00502159

0.99840158
0.99840158

Clu

-5.5170014 0.00549547

0.99840158

Ost4

-3.8280125 0.00673563

0.99840158

Nr4a1
Ppp1r2

-1.1926859 0.00719313
1.83248239 0.00773356

0.99840158
0.99840158

Olfml2b

0.85966541 0.00788509

0.99840158

Fabp4
Cxcl12
Dact1

1.05813254 0.00797546
-1.5410569 0.00852024
-1.8257111 0.00881869

0.99840158
0.99840158
0.99840158

Tmem45a
Pcolce2
Tnc
Vps28

1.43059773
1.1107579
-2.4502615
3.75086737

0.00955276
0.00956473
0.00999735
0.01008683

0.99840158
0.99840158
0.99840158
0.99840158

Tgfbi
Tmem176b
Pid1

-0.7664133 0.01019356
-2.0220566 0.01104565
2.39654834 0.0113067

0.99840158
0.99840158
0.99840158

Dhx38
Dclk1
Slc50a1
Timp2

-3.290346
-2.158695
-3.2325487
0.49646932

0.01174769
0.01407095
0.01636674
0.01638111

0.99840158
0.99840158
0.99840158
0.99840158

Plagl1
Gfpt2
Xdh

0.94202989 0.01768522
1.3709297 0.01830791
0.9646225 0.01964242

0.99840158
0.99840158
0.99840158

Enpp2
Rcor1
Emd
Myh11

-2.7140419
-3.1370543
-3.5054208
-1.3336336

0.02006989
0.0211155
0.02159981
0.02221457

0.99840158
0.99840158
0.99840158
0.99840158

Txndc16
Dpt
Apoe

1.90045346 0.02237822
0.46204607 0.02243401
-1.9356623 0.0226685

0.99840158
0.99840158
0.99840158

Gde1

3.13151533 0.02284337

0.99840158

Plin4
Trpm7

3.17089119 0.02334723
-1.7293731 0.02353939

0.99840158
0.99840158

Ywhaz

-0.9758556 0.02363838

0.99840158

Ddx3x

0.60701298

0.99840158

0.023938

Table 3.1: Top differentially regulated genes in IL-4RaKO compared to WT
according to p-value
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IL-4 receptor signaling in vivo induces no change in adipogenesis of ICAM1+
preadipocytes in vitro
Because we detected no change in gene expression of ICAM1+ preadipocytes
between IL-4RaKO and WT, we hypothesized that adipogenic differentiation of these
preadipocytes in vitro would result in similar levels of white, beige and overall
adipogenesis. Thus, we isolated ICAM1+ preadipocytes from WT and IL-4RaKO mice
and differentiated the cells in vitro. We differentiated preadipocytes for 4 days according
to the experimental scheme shown in Figure 3.3A. In the images after differentiation, IL4RaKO and WT adipocytes both show a robust lipid droplet morphology (Figure 3.3B).
Compared to differentiation of the entire SVC fraction, we saw a more uniform
morphology in culture (Supplemental Figure 3.4). Analysis of in vitro differentiated IL4RaKO ICAM1+ preadipocytes showed no changes in Adipoq nor in CD36 compared to
WT (Figure 3.3C). Similarly, expression of white adipocyte genes (Retn and Leptin) and
beige adipocyte genes (Ucp1 and Prdm16) showed no change in IL-4RaKO ICAM1+
preadipocytes compared to WT. Altogether, the RNA-seq data and in vitro differentiation
experiments suggest that in vivo IL-4 receptor signaling during preadipocyte commitment
does not induce any changes in adipogenesis.
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Figure 3.3: IL-4 receptor signaling in vivo induces no significant change in
adipogenesis of neonatal ICAM1+ preadipocytes in vitro. A) Outline of experimental
method. B) Representative images of ICAM1+ culture before and after differentiation. C)
qRT-PCR analyses of mature adipocyte genes Adipoq and CD36, white adipocyte genes
D) Retn and Lep, and beige adipocyte genes E) Ucp1 and Prdm16.
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Supplemental Figure 3.4: Representative images of IL-4RaKO and WT SVCs
differentiated in vitro
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IL-4 pretreatment increases beiging in neonatal ICAM1+ preadipocytes
Because IL-4 receptor signaling during preadipocyte commitment did not alter
adipogenesis in vitro, we sought to determine whether signaling through the IL-4 receptor
on ICAM1+ preadipocytes could account for the fat mass phenotype observed in vivo
(Figure 1). ICAM1+ preadipocytes were isolated from iWAT of P7-14 WT mice and
plated at confluency. Cultures were next pretreated with 10 nM IL-4 or PBS for 48 hours
and then differentiated (Figure 3.4A). The PBS and IL-4 pretreated cultures showed
similar precursor morphology at Day 0, before differentiation (Figure 3.4B). At Days 4-5,
after differentiation, the PBS and IL-4 pretreated cultures also showed similar lipid
droplet morphology (Figure 3.4C). Gene expression analysis showed that IL-4
pretreatment induced no significant changes in Adipoq and CD36, markers of mature
adipocytes. However, IL-4 pretreatment significantly increased Ucp1 mRNA expression
compared to PBS controls (Figure 3.4D). Prdm16 showed no change after IL-4
pretreatment (Figure 3.4D). Altogether, these data support a model where IL-4 receptor
signaling in ICAM1+ preadipocytes increases beige adipogenesis.
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Figure 3.4: IL-4 pretreatment increases beiging of neonatal ICAM1+ preadipocytes.
Experimental method. B) Representative images of ICAM1+ preadipocyte culture before
pretreatment (Day -2), before differentiation (Day 0) and after differentiation (Day 4).
qRT-PCR was used to quantify C) mature adipocyte genes Adipoq and CD36, white
adipocyte genes D) Retn and Lep, and E) beige adipocyte genes Ucp1 and Prdm16.
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IL-4 during differentiation decreases adipogenesis
Finally, we performed in vitro culture experiments with IL-4 throughout
differentiation to determine if IL-4 receptor signaling changes during differentiation.
ICAM1+ preadipocytes were isolated using FACS from iWAT of P7 mice, plated at
confluency and left to adhere overnight. Next, we added either PBS and Differentiation
media or 10 nM IL-4 and Differentiation media (Figure 3.5A). After 48 hours, we
replaced the media with maintenance media and either PBS or 10 nM IL-4. The
preadipocyte morphology looked similar on Day 0, before differentiation (Figure 3.5B).
After 4-5 days of differentiation, the lipid morphology still looks similar between PBS
and IL-4 controls (Figure 3.5B). We performed qRT-PCR for quantification of
maturation, white adipogenesis and beige adipogenesis of the fully differentiated cultures.
Surprisingly, maturation gene CD36 was significantly downregulated in IL-4 incubated
cultures compared to PBS controls, but there was no change in Adipoq (Figure 3.5C).
These data suggest that IL-4 receptor signaling during differentiation decreases
adipogenic maturation.
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Figure 3.5: IL-4 throughout differentiation decreases adipogenic maturation of
neonatal ICAM1+ preadipocytes. A) Outline of experimental method shows all the
addition of IL-4 to culture during differentiation. B) Representative images of ICAM1+
preadipocytes befor and after differentiation. C) qRT-PCR analysis of Adipoq and CD36
mRNA expression after IL-4 throughout differentiation.
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3.3 Discussion
In this chapter, we determined that IL-4RaKO neonates have increased fat and
decreased beiging compared to WT and identified that IL-4 receptor signaling is inducing
these effects mainly through ICAM1+ preadipocytes. The process of adipogenesis has
been thoroughly analyzed in cell lines and more recently confirmed in primary cultures
from animals (Farmer 2006; Hepler, Vishvanath, and Gupta 2017). However, the
different timepoints of adipogenesis at which adipocyte precursors are open to regulation
have not been thoroughly studied. In this work, we analyzed the role of IL-4 receptor
signaling in neonatal mice and found that loss of IL-4 receptor signaling led to increased
fat mass in P14 mice. This finding is supported by the literature, which shows that IL4RaKO adult mice have increased obesity when fed a high fat diet. It is also supported
by our previous work showing improved glucose tolerance in adulthood after
administration of IL-4 to newborn pups.
In addition, we analyzed RNA-seq data of ICAM1+ preadipocytes from neonatal
IL-4RaKO and WT. ICAM1+ preadipocytes from WT mice were exposed to IL-4
receptor signaling during preadipocyte commitment, whereas ICAM1+ preadipocytes
from IL-4RaKO mice have never been exposed to IL-4 receptor signaling. This
difference in preadipocyte development surprisingly did not result in any statistically
significant differentially regulated genes. We also saw no change in adipocyte
differentiation in IL-4RaKO compared to WT controls. Thus, IL-4 receptor signaling
during preadipocyte commitment does not appear to affect adipogenesis.
Next, we analyzed the role of IL-4 receptor signaling on ICAM1+ preadipocytes
before and during differentiation. Interestingly, we found that IL-4 pretreatment of
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ICAM1+ preadipocytes increased beige adipogenesis. These findings are consistent with
the Chawla lab’s findings that IL-4 pretreatment alters differentiation of adult mouse
SCA1+ preadipocytes (Lee, Odegaard, et al. 2015). Finally, we quantified adipogenesis
after IL-4 was added during differentiation and observed that IL-4 added throughout
differentiation decreases maturation. These new data support our original findings in
neonatal rat SVCs (Ying et al. 2021). In previous studies, Tsao et al also found that IL-4
added during adipogenic differentiation of 3T3-L1 cells decreased adipogenesis (Tsao et
al. 2014; Shiau et al. 2019).
Although we failed to discover differentially regulated genes in IL-4RaKO
ICAM1+ preadipocytes compared to WT, our data suggest that we may find differentially
regulated genes after 48 hours of IL-4 treatment on WT ICAM1+ preadipocytes as well
as after 48 hours of IL-4 co-treatment during differentiation. Therefore, we are planning
to collect samples for further RNA sequencing: 1) after 48 hours of PBS or IL-4
treatment on WT ICAM1+ preadipocytes and 2) after 48 hours of PBS or IL-4 cotreatment with a differentiation cocktail on WT ICAM1+ preadipocytes.
Recent studies also suggest that there may be dysregulation at the chromatin level.
Rajbhandari et al reported that IL-10 signaling induced remodeling of chromatin
architecture at the loci of adipocyte genes, so we expect there may be epigenetic changes
initiated by IL-4 (Rajbhandari et al. 2018). This hypothesis is supported by our previous
study, which showed that neonatal IL-4 induces a long term decrease in differentiation
potential (Ying et al. 2021). Therefore, we plan to perform bulk ATAC-seq on ICAM1+
preadipocytes from neonatal IL-4RaKO and WT.
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From these results, we propose a model in which IL-4 decreases adipogenesis and
increases beiging mainly through reprogramming the preadipocyte during commitment.
Although IL-4 receptor signaling during the first 2 days of differentiation can regulate
overall adipogenesis, it does not induce any changes when it is present throughout the
entire differentiation process. Because that is the most physiologically relevant condition,
these findings altogether suggest that IL-4 receptor signaling is not regulating
adipogenesis in vivo through ICAM1+ cells. We propose that IL-4 receptor signaling in
DPP4+ cells regulates fat development in vivo. These insights into developmental
adipogenesis may help in developing future therapies for obesity and related diseases
(Figure 3.6).
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Figure 3.6: Summary model of IL-4 receptor signaling during development
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CHAPTER 4: FUTURE DIRECTIONS

4.1 Summary
IL-4 is a cytokine that is elevated in neonates compared to adults and it has also
been implicated in the regulation of adipogenesis. Therefore, we did these studies to
determine if IL-4 plays a role in regulating the development of fat in neonatal mice. First
we explored increased IL-4 and loss of function effects of the cytokine IL-4 on neonatal
fat in vivo. Increased neonatal IL-4 decreases weight through impaired white adigonesis,
improved beige adipogenesis and impaired overall adipogenesis. Neonatal IL-4 loss of
function increases weight through improved white adipogenesis, impaired beige
adipogenesis and no change in overall adipogenesis. These findings are significant
because they are the first reported observations in mice where beige adipogenesis has
been altered by P14. Although beige adipogenesis begins at P10, there are no known
signals for beiging between P10 to P14. Prior to this study, no experiment had been able
to alter beige adipogenesis before the age of P21 (Wu et al. 2020).
Next, we examined whether this phenotype was persistant or acute. This question
was important to address because our lab and others have shown that insults during the
postnatal period can lead to persistant effects. We show in Chapter 2 that the neonatal IL4 induced increase in beiging was an acute effect and did not persistent into adulthood.
However, we hypothesize that there is a persistently increased dormant beige-turned
white population that would be identified under cold exposure. Interestingly, exogenous
IL-4 during the developmental period does lead to a persistent decrease in the adipogenic
potential of the adult adipocyte precursor population in rats. This is likely occuring due to

77

IL-4 induced epigenetic changes in the ICAM1+ preadipocytes. These data are imporatnt
because, other than cold exposure, they are the first to show a postnatally induced long
term change in adipose tissue.
In order to perform more precise analyses on homogenous populations, we
determined the specific preadipocyte populations that express IL-4Ra. Using the neonatal
mouse single cell RNA seq dataset from Merrick et al as well as flow cytometry, we
discovered that IL-4Ra expression is concentrated in DPP4+ progenitors and ICAM1+
preadipocytes. This finding creates a basis for more precise analysis of IL-4 signaling in
neonatal fat going forward.
To test whether IL-4 receptor signaling could alter the progenitor to preadipocyte
commitment process, we isolated ICAM1+ preadipocytes and performed RNA-seq to
identify differentially expressed genes in the ICAM1+ preadipocytes from IL-4RaKO
compared to those from WT. Surprisingly, we found no differentially expressed genes.
Also, the differentiated IL-4RaKO ICAM1+ preadipocytes showed no significant change
in white, beige or mature adipogenic markers compared to WT controls. Because IL-4
receptor signaling in vivo during the DPP4+ progenitor to ICAM1+ preadipocyte
commitment process does not alter the ICAM1+ preadipocyte, it is unlikely that IL-4
signaling on DPP4+ progenitors is responsible for the neonatal decreased fat phenotype.
We next tested whether IL-4 receptor signaling on ICAM1+ preadipocytes was the cause
of the phenotype we see in neonates in vivo and found significantly increased beige
adipogenesis compared to WT. These data suggest that the increased beige fat we see in
vivo is likely due to IL-4 receptor signaling on ICAM1+ preadipocytes. However, in vivo
we also saw decreased white adipogenesis and decreased overall adipogenesis in the
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increased IL-4 model. Thus, we tested IL-4 receptor signaling on neonatal ICAM1+
preadipocytes throughout differentiation to determine if IL-4 receptor signaling during
this process would induce decreased white adipogenesis. Surprisingly, we found no
significant changes in white adipogenesis but we did find a significant decrease in
adipogenic maturation. These findings are significant because they reveal that the effects
of neonatal adipocyte precursor signaling can change throughout commitment and
differentiation. This will afffect not only IL-4 receptor signaling, but other signaling
pathways in neonatal adipose tissue.
Altogether, these data support a model whereby IL-4 receptor signaling can
impact neonatal fat development through two distinct mechanisms: 1) regulating beige
adipogenesis of ICAM1+ preadipocytes and 2) regulating maturation of ICAM1+
preadipocytes during the process of differentiation. Because we could not replicate the
IL-4 receptor signaling induced decrease in white adipogenesis within our in vitro
experiments, the decreased white adipogenesis could be an indirect effect of IL-4 within
the in vivo environment.

4.2 Identification of pathways downstream of IL-4 receptor signaling
Immune populations activated in vivo
IL-4 is a cytokine that is secreted by eosinophils and polarizes immune cells such
as T-cells and macrophages toward a type 2 immune response. It has also been suggested
that IL-4 signaling through macrophages produces catecholamines, which trigger
adipogenesis (Qiu et al. 2014). However, this has been disputed (Fischer et al. 2017).
Single cell RNA sequencing has shown that, at the very least, iWAT beiging is associated
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with an increase in type 2 polarized macrophages (M2) (Henriques et al. 2020).
Therefore, IL-4 likely induces some indirect effects on adipogenesis in vivo through M2
polarization. In order to determine indirect effects of neonatal IL-4 through M2
macrophages, a Lyz2Cre IL-4Raf/f mouse could be used to compare adipose tissue to WT.
In addition, a PdgfraCre IL-4Raf/f mouse could be used to compare to WT and determine
direct effects of neonatal IL-4 on the preadipocyte.

Cell Autonomous signaling pathways of preadipocytes
Microarray analyses in adult adipocyte precursors have shown that IL-4 receptor
signaling upregulates DNA replication, cell cycle entry, and mitosis as well as
downregulates triglyceride metabolism and lipid biogenesis (Heredia et al. 2013). These
data in adult adipose tissue support the hypothesis that IL-4 receptor signaling inhibits
adipogenic maturation, but has yet to be confirmed using neonatal adipose tissue.
Although we performed RNA-seq on neonatal preadipocytes from WT compared to IL4RaKO, we did not find any significantly differentially regulated genes. This could be
due to using only a preadipocyte population, which we would not expect to have
triglyceride metabolism or lipid biogenesis. Bulk RNA sequencing will need to be
performed on the whole neonatal adipose tissue depot to look at mature adipocytes in
vivo.
The signaling pathways that mediate this inhibition are also unknown. IL-4 has
been reported to activate three major signaling pathways in adult mice adipogenic
progenitors marked by CD31-CD45-a7integrin-SCA1+ (Heredia et al. 2013). Howver,
the activation of these signaling pathways have not been confirmed in neonatal mice, nor
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in CD31-CD45-ICAM1+ preadipocytes. These three pathways are signal transducer of
transcription 6 (STAT6), the protein kinase AKT, and the extracellular signal-regulated
protein kinases (ERKs) (Heredia et al. 2013).
AKT kinases could be potential mediators of IL-4 induced inhibition of
adipogenic differentiation. The phosphoinositide 3-kinase (P13K)-AKT pathway
regulates cellular growth, survival and metabolism through several kinases and can be
blocked by P13K inhibitors (Huang et al. 2018). AKT1 and AKT2 are the major kinases
in mammals; AKT1 promotes growth in many tissues, while AKT2 regulates metabolism
in liver, muscle, and adipose tissue (Jeffery et al. 2015). In the muscle and liver of adult
mice, IL-4 administration increases phosphorylation of AKT (Ricardo-Gonzalez et al.
2010). In addition, expansion of adipocyte size in obesity requires AKT phosphorylation
in adipocyte progenitors of visceral WAT (Jeffery et al. 2015). However, AKT2-/- mice
show normal WAT development and fat mass up to 6 weeks of age, making it an unlikely
signaling pathway for IL-4 induced decreased fat in neonates (Jeffery et al. 2015).
ERK1/2 could also be a signaling pathway for IL-4 induced decreased
adipogenesis. The ERK pathway is essential for cellular functions such as proliferation
and differentiation (Bost et al. 2005). During development, a number of labs have
observed that Erk1-/- mice are leaner and have less fat mass compared to WT mice (Khan
et al. 2017; Bost et al. 2005). These observations suggest that ERK1/2 normally
contributes to adipogenesis in the developing animal. This is in contrast to IL-4, which
decreases adipogenesis in the neonate. In addition, activation of ERK1/2 during
adipogenic differentiation was partially suppressed by IL-4 throughout differentiation in
3T3-L1 cells (Tsao et al. 2014). Therefore, these data altogether suggest it is unlikely that
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IL-4 receptor signals through the ERK1/2 pathway to decrease adipogenesis in neonates.
MEK1 inhibitors, which block the ERK pathway, can be used in conjunction with IL-4 in
vitro to determine if ERK1/2 is required for IL-4 induced changes in adipogenesis.
Although IL-4 receptor signaling could activate AKT kinases and ERK1/2, most
cells require the transcription factor STAT6 for cellular reprogramming (Goenka and
Kaplan 2011; Maier, Duschl, and Horejs-Hoeck 2012). There are 7 members of the
STAT protein family. STATs 1, 3, 5A and STAT6 have all been detected in adipose
tissue and 3T3-L1 cells (Stephens, Morrison, and Pilch 1996). However, IL-4 has only
been shown to phosphorylate STAT6, and only in preadipocytes (Deng et al. 2000). In
vivo, IL-4 induces proliferation of adipocyte progenitors in adult WT mice, but not in
adult STAT6-/- mice. Fat mass is also decreased in STAT6-/- mice at 8-16 weeks of age
(Heredia et al. 2013). These data are from adult mice but support the hypothesis that IL-4
may be signaling through STAT6 to decrease adipogenesis in neonates. To test this
hypothesis, we would need to quantify the weight and fat mass of STAT6-/- mice at
neonatal timepoints.
Again, we did not have any signifcantly differentially expressed genes in WT
preadipocytes (CD31-CD45-ICAM1+) compared to IL-4RaKO preadipocytes for
pathway analysis. For future experiments, activation of these pathways could be validated
in neonates at the protein level using flow cytometry, western blots or ELISAs. In
addition, it will be important to differentiate between IL-4 activation of a preadipocyte’s
pathway before differentiation compared to during differentiation. Finally, although all
pathways could be activated, that does not neccesarily mean they are all required for IL-4
receptor signaling induced decrease in fat. Thus, after validating activated pathways, it
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will be important to knock out each one by one and in groups to identify which are
required for the phenotype.

4.3 Preadipocyte regulation
In the neonatal rat, increased IL-4 receptor signaling in vivo leads to an acute and
persistent decrease in maturation of the adipocyte precursor population after
differentiation in vitro, also known as decreased adipogenic potential. However, when we
performed experiments in neonatal IL-4RaKO and WT mice, we found that the decrease
in IL-4 receptor signaling in vivo did not increase adipogenic potential of IL-4RaKO
adipocyte precursors. We also saw no significant changes in differentiation from
ICAM1+ preadipocytes isolated from WT and IL-4RaKO. One explanation for this
discrepency could be that WT Balbc mice do not have enough IL-4 receptor signaling to
meet the threshold necessary to induce this decrease in adipogenic potential. Although
WT Balbc mice are known to be highly Th2 polarized, our neonatal rat IL-4 injections
increased serum IL-4 levels from ~100 pg/ml to ~1000 pg/ml. For comparison, neonatal
WT Balbc mice had serum IL-4 levels of ~45 pg/ml (Supplemental Figure 3.1). In order
to determine whether IL-4 does decrease adipogenic potential, future experiments will
require an adipocyte precursor specific IL-4 overexpression transgenic mouse.
It is important to note that our neonatal rat IL-4 injections increased IL-4 in serum
to non-physiologic levels. However, under some disease conditions such as intrauterine
growth restriction (IUGR), IL-4 levels are significantly elevated (Jaeckle Santos et al.
2014). Furthermore, in IL-4RaKO mice compared to WT, we observe corresponding
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effects and effect sizes comparable to what we report in rats injected with IL-4, strongly
supporting a role for IL-4 in normal adipogenesis.

Changes in population distribution
In iWAT of neonatal mice, we see no change in the DPP4+ population between
IL-4RaKO and WT. However, IL-4RaKO does have a decreased ICAM1+ population
compared to WT. One explanation for the change in population distribution is that IL-4
receptor signaling is increasing proliferation of ICAM1+ preadipocytes. In vitro, we have
shown that IL-4 increases proliferation of neonatal rat adipocytes precursors and the
Chawla lab showed that the same process occurs in adult mice adipocyte precursors (Lee,
Odegaard, et al. 2015). Coupled with the increase in ICAM1+ preadipocytes we observed
in WT compared to IL-4RaKO, these data together suggest that IL-4 receptor signaling
on ICAM1+ preadipocytes increase their proliferation. In order to directly test this
hypothesis, the same number of ICAM1+ preadipocytes would need to be plated and
incubated with either IL-4 or PBS in vitro and then counted after 48 hours.
Another explanation for the increased ICAM1+ population in WT compared to
IL-4RaKO is that IL-4 receptor signaling is increasing the transition of DPP4+ cells to
ICAM1+ cells. In IL-4RaKO pups, DPP4+ progenitors develop into ICAM1+
preadipocytes without exposure to IL-4 receptor signaling. Our bulk RNA sequencing
shows no significant differentially regulated genes in ICAM1+ preadipocytes from IL4RaKO compared to WT. This suggests that IL-4 does not regulate the process of DPP4+
progenitors commiting to the adipocyte lineage and gaining preadipocyte markers. In
order to directly test whether IL-4 affects this commitment process, DPP4+ progenitors
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need to be isolated using FACS and differentiated with a full adipogenesis cocktail in
vitro with and without IL-4.
A decrease in any precursor population could lead to decreased adipogenesis,
which occurs in adult mouse eWAT where there is less adipogenesis due to a decrease in
the DPP4+ progenitor population (Merrick et al. 2019). Although a decreased ICAM1+
population could result in decreased adipogenesis, we do not see this in vitro. This may
be an example of the differences between eWAT and iWAT. The Seale lab has also
reported that the iWAT precursor population remains the same under cold conditions and
old age (Merrick et al. 2019). Although the decreased ICAM1+ population in IL-4RaKO
does not lead to decreased adipogenesis in vitro, it could lead to decreased adipogenesis
in vivo. However, we see that IL-4RaKO mice weigh more and have greater fat mass
compared to WT. Thus, the decreased ICAM1+ population does not seem to have a
functional effect on fat development.

Evidence for epigenetic remodeling
Although we did not find any differences in gene expression in our bulk RNA
sequencing experiments between IL-4RaKO ICAM1+ preadipocytes compared to WT, it
is possible that later in life or in response to external stimuli such as a high fat diet there
could be changes in the transcriptome. Assessing the epigenome could identify
susceptible loci. This is supported by a recent publication from the Granneman lab, which
shows that chromatin accessibility from P6 to P56 drastically shifts (Rondini et al. 2021).
In addition, Rajbhandari et al showed that the type 2 cyotkine IL-10 regulates
adipogenesis by altering the chromatin architecture (Rajbhandari et al. 2018). They used
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an immortalized brown-like preadipocyte cell line that expressed IL-10Ra (iBAd cells)
as well as iWAT and showed that IL-10 inhibited thermogenesis by repressing chromatin
accessibility in key enhancer regions (Rajbhandari et al. 2018). IL-4 has been shown to
activate STAT6 in macrophages and alter gene expression through epigenetic mechanims
(Hsu et al. 2018). Because IL-4 likely inhibits thermogenesis through STAT6 activation,
ATAC-seq of iWAT in IL-4RaKO neonatal mice could show whether the mature fat has
inaccessible chromatin at loci that regulate thermogenic genes (Qiu et al. 2014).
Another lab reported that BAF60, a SWI/SNF chromatin remodeling complex
subunit, maintains chromatin accessibility at PPARg and EBF2 binding sites at key
thermogenic genes in brown fat (Liu et al. 2020). ATAC-seq showed remarkable overlap
(75.7%) between iWAT from cold-acclimated animals and that of BAT (Liu et al. 2020).
However, they also showed that BAF60 impairs beige fat formation (Liu et al. 2020).
These data again highlight that, although beige and brown adipocytes show similar gene
expression patterns under thermogenic stress, their regulatory mechanisms are distinct at
the epigenetic level. Although phosphorylated STAT6 has been implicated in
preadipocytes downstream of IL-4 receptor signaling, STAT6 is a transcription factor that
binds various genetic loci. ChIP-seq studies would identify differential STAT6 binding in
preadipocytes after IL-4 exposure compared to PBS control.
Bulk ATAC-seq experiments are limited by the heterogenous populations of cells
that make up fat tissue. Because IL-4 receptor signaling in neonates mainly occurs in
ICAM1+ preadipocytes, using SVCs for ATAC-seq could mask any differentially open
or closed regions. Using FACS to isolate ICAM1+ preadipocytes for ATAC-seq would
yield more insight into chromatin remodeling that is specific to this neonatal cell type.
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Also, single-cell ATAC-seq is a new technology that would allow for more precise
analysis of chromatin architecture in preadipocytes.

4.4 Determine the mechanisms of neonatal beige adipogenesis
De novo beige adipogenesis and transdifferentiation
Beige adipogenesis can occur through two different pathways: 1) De novo
adipognesis from a preadipocyte or 2) transdifferentiation from mature white adipocytes
(Lee, Petkova, et al. 2015; Barbatelli et al. 2010; Wang et al. 2013). Cold signaling
throught the sympathetic nervous system releases b-adrenergic receptor agonists to
stimulate beige adipogenesis in adult mice, which leads primarily to transdifferentiation.
De novo beige adipogenesis primarily occurs in developing mice.
The first reports describing beige adipogenesis in the developing animal were in
retriperitoneal fat and mammary adipose tissue (Xue et al. 2007; Gouon-Evans and
Pollard 2002). Adipose tissue has been shown to undergo beiging primarily through cold
exposure. Acute cold stress occurs for ~9 days after birth before mice develop a coat of
fur. Interestingly, Ucp1 mRNA is not detected until ∼10 days of age. One explanation is
that the hypothalamic-pituitary-adrenal axis controlling beiging in the mouse is activated
at around day 12 of postnatal development (Schmidt et al. 2003). However, that does not
explain the presence of Ucp1 mRNA at 10 days of age (Xue et al. 2007). Another
explanation is that initial formation of beige adipocytes during development could be due
to other mechanisms (Xue et al. 2007). Analysis of gene expression in iWAT revealed
that major development of WAT occurred prior to P14 and that much of it was
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independent of the ambient temperature (Wu et al. 2020). However, the mechanisms of
neonatal beige adipogenesis are unknown.
Using ICAM1+ preadipocytes from neonatal mice, it is IL-4 pretreatment prior to
differentiation that increases Ucp1 expression. However, in neonatal rats Ucp1
expression was induced when IL-4 was added during the terminal stages of adipogenesis,
when cells still retained a preadipocyte phenotype without lipid. One explanation for this
discrepency is that IL-4 receptor signaling may be more effective prior to differentiation
in mice and more effective during differentiation in rats. This is not surprising as there
has even been reports of differing beige adipogenesis between strains of mice (Xue et al.
2007). Because of this discrepency, it would be prudent to perform RNA-seq on: 1)PBS
and IL-4 pretreated preadipocytes from WT mice and 2)PBS or IL-4 during terminal
differentiation of rats. A comparison of the two data sets to find upregulated and
downregulated genes in common would determine whether both IL-4 treatments are
activating the same beiging transcriptional network.

Localization of beige adipose tissue
The association of the sympathetic nervous system with beige adipocytes has also
been explored in great detail. It has long been known that cold exposure signals through
the sympathetic nervous system using b-adrenergic receptor signaling to induce
thermogenesis (Collins 2011; Young, Arch, and Ashwell 1984). There is dense
sympathetic innervation in both interscapular BAT (brown) and inguinal WAT (beige),
and sparse innervationin in intra-abdominal WAT (white) (Murano et al. 2009). In adult
mice, sympathetic nervous sytem denervation of iWAT through injection of 6-
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hydroxydopamine (6-OHDA) also downregulates UCP1 protein expression (Cao et al.
2019). In developing animals, doxycycline induced deletion of beige adipocytes during
the postnatal period blocks development of dense innervation even into adulthood (Chi et
al. 2021). In addition, constitutive deletion of Prdm16, a transcription factor that activates
Ucp1, leads to a decrease in sympathetic density during early development (Chi et al.
2021; Chi et al. 2018). These data suggest that there may be a feedback loop between the
developing sympathetic neurites and the developing beige fat.
However, removal of the beige adipocytes after complete innervation has no
effect on the already innervated depot. This suggests that beige adipocytes are only
required during the developmental period of fat innervation and not the maintenance
period. But is innervation required for beige adipogenesis in developing animals? The
Chawla lab showed that innervation is not required for neonatal beige adipogenesis, but
does seem to be required for adult beige adipogenesis (Wu et al. 2020).
Another recent publication discussed a leptin-mediated central regulation of
sympathetic innervation in adipose tissue (Wang, Loh, et al. 2020). This was shown both
in adult mice and neonatal mice, but physiologically there is a postnatal leptin surge that
occurs in developing mice. Loss of leptin during this period impairs beige adipocyte
development and decreases innervation. Because innervation has been shown to be a
major source of developmental beige adipogenesis in neonates, an important future
experiment would be to determine whether IL-4 receptor signaling can alter sympathetic
density in neonatal fat.
In this area of research, the Cohen lab has used 3-D whole tissue imaging to map
out beige lobules within iWAT (Chi et al. 2018). They found that beige adipocytes
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marked by UCP1 protein appear as early as P6 in mice that were born and housed at
room temperature. Between P21 and P28, beige adipocyte quantity and patterning
becomes comparable to adult animals after cold exposure. This thermogenic signature
decreases from P28 onwards, suggesting that these developmental beige adipocytes
become inactivated and reactivated in adulthood during cold exposure (Chi et al. 2021).
Interestingly, Ucp1 mRNA peaked at P14 suggesting that there is translational regulation
of Ucp1 during development. Because we see that IL-4 induces beige adipogenesis in the
neonate, 3-D whole tissue could be used to dissect how this is presented morphologically;
whether IL-4 increases the quantity of beige lobules or increases the size of beige lobules
between IL-4RaKO and WT neonates. In addition, 3-D whole tissue imaging could be
used to gain a more detailed understanding of the correlation between innervation and
beige fat development with and without IL-4.

Markers of beige preadipocytes
UCP1 is the key marker of thermogenesis, but it is present only in mature brown
and beige adipocytes and not in preadipocytes. Beige adipocytes seemingly develop from
the same PDGFRa+ preadipocyte population as white adipocytes (Gao et al. 2018).
Recently, a new beige adipocyte progenitor population expressing Myod has been
identified in mouse iWAT (Chen et al. 2019). Prior studies of beige adipogenesis have
focused on ß-adrenergic receptor (b-ARs) signaling from cold exposure. However, there
have been multiple reports that b-ARs signaling is not required for cold induced beige
adipogenesis (Ye et al. 2013; Razzoli et al. 2016). MYOD+ progenitors do not normally
undergo adipogenesis, but were found to express Ucp1 in iWAT of mice in the absence
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of b-ARs signaling (b-less mice). Thus, there are canonical (PDGFRa+) and noncanonical (MYOD+) progenitor populations that develop into beige adipocytes.
Because developmental preadipocytes are distinct from adult preadipocytes, beige
preadipocyte markers found in adult animals cannot necessarily be used in developing
animals. In post-weaning mice, the Chawla lab observed that Tmem26, Tnfrsf9 and
Klhl13 were beige lineage markers, upregulated in beige preadipocytes (Lee, Odegaard,
et al. 2015). We also observed Tmem26 upregulation in beige preadipocytes from
neonatal rats (Figure 2.4). Tmem26 has also been found to be a distinct beige- versus
brown fat selective marker in adult mice (Harms and Seale 2013). Ebf2 is another beige
marker which has been detected at embryonic day 14.5 in PDGFRa+ precursors (Wang
et al. 2014). Ebf2 expression marks cells that develop into both brown and beige
adipocytes, but Ebf2 expression within PDGFRa+ precursors marks beige specific
precursors (Wang et al. 2014). Interestingly, single cell RNA sequencing was unable to
identify a beige specific preadipocyte cluster after 24 hour cold exposure (Sakers 2019).
This suggests that, although there may be potential markers of beige adipogenesis, beige
preadipocyte global gene expression is very similar to white preadipocytes. We
hypothesize that a longer cold exposure followed by single cell RNA-sequencing or subclustering the existing data set may reveal a beige preadipocyte population. Subclustering will be discussed more in the next section.
The current model of beige adipogenesis can be seperated into three phases: 1)
temperature independent neonatal de novo beige adipogenesis, 2) temperature dependent
preweaning de novo beige adipogenesis and 3) adult beiging through de novo
adipogenesis of adult preadipocytes and/or transdifferentiation. In the first phase, P10-
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P14 mice undergo de novo beige adipogenesis which is temperature independent.
Between P21-P28, cold exposure has been reported to increase de novo beige
adipogenesis (Wu et al. 2020). These first two phases of de novo adipogenesis establish
the pool of beige adipocytes that can be activated in the second phase. By P35, these
beige adipocytes will have begun to transdifferentiate into white adipocytes. In the third
phase, P56 (8 week old) mice that are exposed to cold either go through de novo beige
adipogenesis of adult preadipocytes or activate the transdifferentiation of the pool of
dormant beige (also known as beige-turned-white) adipocytes that were established
during development (phases one and two) (Figure 4.1) (Wu et al. 2020).
Within this model, we hypothesize that IL-4 is pushing preadipocytes toward a
beige lineage during the first phase of de novo adipogenesis. This supposes that ICAM1+
preadipocytes are not yet committed to white or beige adipogenesis. Data from the
Granneman lab showing that PDGFRa+ precursors from gonadal WAT could develop
into beige or white adipocytes depending on treatment conditions supports this idea (Lee
et al. 2012). Cold exposure in adult mice has also been shown to increase adipocyte
precursors’ expression of Ebf2, leading to increased beiging (Wang et al. 2014). Our data,
which shows IL-4 induction of Tmem26 in neonatal adipocyte precursors, also support
this hypothesis (Figure 2.4). In addition, mice reared from birth to weaning at different
temperatures have shown also that cold can increase beige adipogenesis long term
(Chabowska-Kita et al. 2015). As we report in this work, IL-4 receptor signaling could be
inducing the first beige adipocytes in neonates. Further experiments measuring fat mass
in P10-P14 PdgfraCre IL-4Raf/f compared to WT would confirm initial beiging as a direct
effect of IL-4 in vivo.
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This model limits transdifferentiation to the pool of beige-turned-white
adipocytees that were committed during neonatal development. There are actually
multiple reports that link the limitation of adult beiging to the amount of beige
adipogenesis during postnatal development (Wu et al. 2020; Chabowska-Kita et al.
2015). However, the magnitude of transdifferentiation compared to de novo beige
adipogenesis that occurs in adult animals is unclear. Using 129S1/SvImJ mice, the
Granneman lab found approximately 90% of beige adipocytes induced by b-adrenergic
receptor agonists in 8 week old iWAT are derived from adipocytes that were already
mature at 3 weeks of age (Contreras et al. 2014). However, the Graff lab found that, in
C57BL/6J and 129SV mixed background, 60-70% of beige adipocytes formed de novo
after cold exposure in 8 week mice iWAT (Berry, Jiang, and Graff 2016). The
discrepency in magnitude of adult de novo beiging could be due to the different strains of
mice used. Because IL-4 receptor signaling only alters de novo beige adipogenesis, the
differing magnitude of this in adult mice could account for the discrepencies seen in adult
IL-4 induced beiging experiments from Qiu et al and Fischer et al.

93

Figure 4.1: Model of beige adipogenesis in development up to adulthood
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4.5 Use bioinformatic tools to isolate developmental and adult
preadipocytes
An increasing number of human and mouse studies point to the mural cell
compartment of the vasculature as a home for adult adipocyte precursors (Yuan et al.
2014; Jiang et al. 2014). Unfortunately, this hypothesis has not been supported by
pseudotime analysis of single-cell data. Further studies will need to be done to clarify the
linage and localization of these adipocyte precursors.
Merrick et al performed single cell RNA sequencing and found that preadipocyte
factor 1 (Pref1) expression is limited to the ICAM1+ population in developing (p12) mice
and is not present in adult (8 week) mice ICAM1 cells. This isolates Pref1 as distinct
marker of developmental adipocyte precursors (Sakers 2019). The Sul lab reported that
deletion of Pref1+ cells prevents embryionic WAT development and leads to decreased
fat expansion in adult animals (Hudak et al. 2014). Their model suggests that
developmental precursors, not adult precursors, are responsible for fat expansion in
obesity in adulthood. This correlates well with Jiang et al, who found that deletion of
adult precursors disrupts fat homeostasis in adult animals. The Pref1+ cells also do not
localize to the vasculature, a feature of adult precursors. In future experiments, an
inducible IL-4RaKO on the Pref1-/- background mice could be used to determine
whether neonatal IL-4 induces long term effects by signaling through adult preadipocytes
during the developmental period. We would expect to see that the IL-4 exposure during
development leads to decreased adult fat compared to the unexposed Pref1-/-.

Sub-clustering of ICAM1+ preadipocytes
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The ICAM1+ population expresses both Pparg and Pref1, which has been
reported to exist in distinct populations on the adipogenesis precursor timeline (Hudak et
al. 2014). Pdgfra and Pparg are also expressed on mutually exclusive populations (Sun,
Berry, and Olson 2017). PREF1+ PDGFRa+ adipocyte precursors downregulate Pref1
and Pdgfa expression before Pparg expression can be upregulated. Therefore, the
ICAM1+ population must still retain some heterogeneity even though it is independently
clustered (Figure 4.2).
Independent clustering of SVC single cell RNA sequencing data maps together
cells that are alike in gene expression. This leads to accurate identification of adipocytes,
fibroblasts, macrophages, and adipocyte precursor populations. However, even cells that
are mostly similar will have a small number of diferentially expressed genes. To further
disentangle the adipogenesis precursor timeline, ICAM1+ cells could be isolated for subclustering. Sub-clustering would be independent clustering only within the ICAM1+ cells
instead of assessing all SVCs. Using this method, sub-populations with biological
significance could be isolated. In the literature, sub-clustering has been used to separate
out resident macrophage, M1 macrophage, M2 macrophage, neutrophils and dendritic
cell populations from a macrophage-like cluster generated from iWAT SVCs (Henriques
et al. 2020). Sub-clustering may even identify a dinstinct population within ICAM1+
preadipocytes that expresss IL-4Ra.
Similar to how brown and beige fat share overlapping transcriptional
programming, the current literature suggests that developmental and adult precursors
have very similar gene expression patterns. Specifically, their expression patterns are so
similar that they do not cluster independently during single-cell RNA-seq (Sakers 2019).
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Therefore, sub-clustering of ICAM1+ preadipocytes could isolate the developmental and
adult preadipocytes and identify useful markers for further studies.
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Figure 4.2: Marker of developmental preadipocytes sub-clustered within ICAM1+
preadipocyte pool
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Pseudotime analyses
After sub-clustering, pseudotime analyses can be used on the different clusters to
form an adipogenesis timeline. This would be useful to validate what has been found in
vivo, such as the PREF1+ progression to PDGFRa+ and then to PPARg+ expressing
cells.
Distinguishing the developmental and adult preadipocyte populations may shed
light on factors governing their different physiological properties. Experiments focused
on clarifying whether adult and developmental adipocyte precursors have different
ontogeny or just diverge with age will be the most important. A main goal would be to
manipulate adult adipose tissue towards growth via hyperplasia, which is linked to better
outcomes than hypertrophy.

4.6 Clinical Applications
In utero, the prevailing model is that Th2 anti-inflammatory cells reduce Th1
inflammation and promote organogenesis (Rackaityte and Halkias 2020). Th1
inflammation may harm healthy pregnancies, with human cord blood from preterm
newborns showing an enrichment of Th1 cells (Luciano et al. 2011). Clinical
observations have also found decreased levels of Th2 cytokines in women who have
spontaneous abortions, recurrent miscarriages, small for gestational age babies, and
infertility (Xiao et al. 2013). Progesterone, an important steroid hormaone for
establishing and maintaining pregnancy, induces the production of Th2 cytokine IL-4
(Joachim et al. 2003). In addition, fetal cord blood naïve T cells produce an
unglycosylated isoform of IL-4 (Webster et al. 2007).
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Th2 cell function and specificity has not been thouroughly investigated in the
fetus outside of cord blood, but IL-4 producing cells have been found in the fetal intestine
(Schreurs et al. 2019). In the newborn, serum IL-4 is increased compared to adults and
this is coincident with the beginning of fat development, specifically the induction of
beige adipocytes in iWAT. Evolutionarily, this may be how IL-4 receptor signaling
became a regulator of fat development.
Through clinical studies, longitudinal profiling could be used to quantify beige fat
in children to determine if it correlates to beiging potential in adults. This could be done
by MRI imaging of thermogenic fat in children, followed by PET/CT scans in adults after
activation with a b3-adrenergic receptor agonist such as mirabegron (Sampath et al.
2016; Rasmussen et al. 2013). Understanding the extent that beiging in human adults may
be connected to childhood beige depots will be necessary for the development of more
precise drugs.
Current therapies directed at the pathways regulating cold induced beiging as a
treatment for obesity have been unsuccessful to date. Several new mechanisms for
beiging have been recently proposed, including thyroid hormone, bone morphogenetic
protein 8a, irisin, retinoids and bile acids (Ziętak, Chabowska-Kita, and Kozak 2017).
There is also evidence that different mechanisms can produce distinct beige adipocytes
(Li et al. 2021). IL-4 has been consistently reported to induce beige adipocytes and they
may be functionally different than cold-induced beige adipocytes. Therefore, targeting
IL-4 induced beiging may be better suited for clinical applications.

4.7 Conclusion
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It is becoming increasingly clear that understanding the postnatal development of
adipose tissue will be critical for improving outcomes not only in childhood obesity, but
also in adult obesity. As well as other important neonatal signals such as BCL6, my data
suggest that IL-4 receptor signaling is a key regulator of neonatal adipogenesis (Wu et al.
2020). Analysis of the downstream signaling pathways of IL-4 receptor signaling will be
required to gain more insight. Specifically, ATAC-seq and ChIP seq experiments will
elucidate the mechanisms involved in the regulation of preadipocytes. In addition, there is
increasing interest in neonatal beiging and how it is regulated. Now that it is generally
accepted as distinct from adult beiging, further studies of the contribution of IL-4
receptor signaling could add clarity to discordant research studies. Finally, pseudo-time
analysis will alsbe a useful tool for identification of developmental preadipocytes.
Although the field of adipocyte biology has advanced from working exclusively
in 3T3-L1 cell lines, there are still improvements to be made in standardizing mouse
models and methodology. Although there have been in vitro studies on primary adipocyte
precursors isolated from iWAT, there is a large variety and combination of markers used
in selecting ‘preadipocytes’. Standardizing the required markers for preadipocytes would
be an important step toward establishing concordance of results from different labs. In
addition, my research along with others support transparency in reporting ages of animals
used in studies on adipose tissue. This in itself could be the source of multiple discordant
data sets. Finally, there exist a number of inducible preadipocyte specific genetic mouse
models that have been developed that could be very useful if they were made available to
the larger scientific community. Since it is more physiological, in vivo temporally
controlled lineage tracing may be more useful than in vitro isolation transcriptomics

101

going forward. These future directions will further our understanding of adipogenesis
regulation, adipocyte populations and the differences between adipose tissue
development and pathology.
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MATERIALS AND METHODS
Animals
Sprague Dawley 2 month old timed pregnant rats were obtained from Charles
River Laboratories and all transported at e17. They were housed at 22°C (unless
otherwise stated) in the vivarium under a 12-hour light and dark cycle. Litters were
randomly adjusted to an n of 8 and only males were used in these studies. Litters were
randomly divided into two treatment groups: Vehicle (PBS) or IL-4 (Peprotech). 1 X
PBS, 50 ng IL-4 or 100 ng IL-4 was made up in a volume of 100 𝜇L daily for injections
subcutaneously at the nape of the neck during the first 6 days of life. No rat pups were
cannibalized. C57Bl/6, Balbc and IL-4RaKO mice were obtained from JAX laboratories
at 9 weeks old and housed at 22°C (unless otherwise stated) in the vivarium under a 12hour light and dark cycle. Both males and females were used. Mice were mated from 9
weeks to 6 months of age.
Single pups in litters counted as an n of 1, and each litter counted as a biological
replicate and each experiment had a minimum of 3 biological replicates. Pups were either
euthanized at P14 for downstream analyses or weaned at 3 weeks of age and then fed
normal chow until 10 weeks of age. Euthanasia of pups was performed by decapitation
before weaning. After weaning, animals were weighed weekly until euthanized at 10
weeks of age using a CO2 chamber followed by bilateral thoracotomy for rats and
cervical dislocation for mice. The animal work was conducted with the approval of the
University of Pennsylvania and the Children’s Hospital of Philadelphia Institutional
Animal Care and Use Committees. The animals were treated humanely with due
consideration to the alleviation of distress and discomfort.
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Fasting blood glucose
10 week old rats were fasted for 6 hours before taking blood glucose measurements.
Blood was taken from the tail vein and measured using the OnePlusUltra2 blood glucose
monitor and blood glucose monitor strips.

Dual X-ray absorbance
At P14, pups were anesthetized using Pentobarbital injected intra-peritoneal at 50
mg/kg body weight. Body composition was measured in animals from each treatment
group using the Lunar PIXImus2 Dual X-ray Absorbance (DEXA) from the neck down,
excluding the head. This machine includes software suitable for small animals. The
percentage of fat and lean tissue per animal was calculated per gram of total body weight.

Isolation of fat depots
Interscapular BAT, inguinal WAT and epididymal WAT were surgically removed
from animals and weighed. Samples were then flash frozen in liquid nitrogen for qRTPCR analysis, fixed for histology or digested for isolation of stromal vascular cells.

Histology
Tissues were fixed with 10% formalin overnight. The tissues were then
dehydrated through a series of ethanol washes: 1) 30% EtOH, 2) 50% EtOH, 3) 70%
EtOH, 4) 70% EtOH, 5) 90% EtOH, 6) 90% EtOH, 7) 100% EtOH and 8) 100% EtOH.
For rat, the fat tissue was large and so they were kept in each ethanol wash for 24 hours.
Then they were embedded in paraffin for thin sectioning. Slides were stained either with
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hematoxylin and eosin or with the following antibodies: Ki67 (Abcam), UCP1 (Abcam),
CD68 (Abcam), and CD3 (BD Pharmingen). For antibody staining, samples underwent
antigen retrieval and peroxide wash followed by blocking for 2 hours in 10% goat serum
with 1% BSA. Images were captured on a Leica DMRBE microscope with 20x
magnification and QImaging Micropublisher 5.0 RTV camera. iVision software version
4.0.16 was used for acquisition, and Aperio software was used for IHC quantification.
ImageJ version 1.52 was used for cell size quantification and cells were excluded if they
bordered the image edge. For Ki67 staining, 3 fields of view from 3 different sections for
each cohort were used and approximately 500 cells were counted in each section. For
calculating the average cell size, 1 field of view from 3 different sections for each cohort
were used and approximately 50 cells were measured in each section.

Serum IL-4
To measure IL-4 concentration in serum in rat pups, IL-4 was injected subcutaneously at
the nape of the neck at postnatal day 1 (P1) and blood was collected approximately 5
minutes later by decapitation for blood collection. To measure IL-4 levels in serum of
Balbc and C57BL6 mice pups, pups were decapitated for blood collection. Blood was
allowed to clot for 30 minutes on ice and then centrifuged for 10 minutes at 12,000 g in
4°C. The clear supernatant was collected as serum. Rat (Invitrogen BMS628) and mouse
(Invitrogen BMS613) IL-4 ELISAs were used for IL-4 analysis and quantified using a
SpectraMax Microplate Reader and SoftMax 7 software.

Glucose stimulated insulin secretion
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Islets were isolated from P14 rats and preincubated first with 0 mM glucose RPMI 1640
for 1 hour at 37°C. Then the supernatant was collected and 2.8 mM glucose RPMI 1640
was added for 1 hour incubation at 37°C. Finally, the supernatant was collected and 16.7
mM glucose RPMI1640 was then added. The supernatant was again collected and the 0
mM, 2.8 mM and 16.7 mM glucose supernatants were quantified for insulin. The insulin
level in the supernatants were analyzed using a Rat Insulin ELISA kit (CrystalChem
90060) and measured using a SpectraMax Microplate Reader and SoftMax 7 software.
Insulin levels were normalized to protein level as quantified using the Pierce BCA
Protein Assay. For the stepwise perifusion, the protocol included supernatant sampling
every 5 minutes. For the GRAMP, the protocol added glucose incrementally at 1 mM
every minute and sampled the supernatant every 3 minutes.

Processing of stromal vascular cells (SVCs)
Adipose tissues from P3 and P7 controls as well as P7 IL-4 treated animals were
manually minced and digested with collagenase D (1.5 units/ml; Roche) and dispase II
(2.4 units/ml; Roche) in DMEM/F12 containing 0.8% fatty acid-free bovine serum
albumin (Sigma) at 37°C for 45 minutes and vortexed for 15 s at 15 min intervals. The
digestion was quenched with DMEM/F12 containing 10% FBS, and the cells were passed
through a 230 µM steel mesh filter followed by centrifugation at 400 x g for 5 min. The
supernatant, containing mature adipocytes, was then aspirated and the pellet, containing
SVCs, was resuspended in ACK lysis buffer (0.15M NH4Cl, 0.01M KHCO3 and
0.0001M Na2EDTA) for 2 min at RT and then quenched in DMEM/F12 containing 10%
FBS. Cells were then collected by centrifugation at 400 x g for 5 min and resuspended in
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FACS buffer (HBSS containing 1% FBS and 5mM EDTA) for cell counting, cell culture
and flow cytometry.

Flow cytometry
SVCs from P7 rats were resuspended in FACS buffer before incubation with the
following antibodies for 30 minutes at 4°C: CD26-FITC (Biolegend, 137806, 1:200);
ICAM1-PE/Cy7 (Biolegend, 116122, 1:100), CD45-APC/Cy7 (Biolegend, 103116,
1:1000), CD31-APC/FIRE (Biolegend, 102528, 1:1000). DAPI (Roche, 10236276001,
1:10000) was added for the final 5 minutes. The cells were washed with FACS buffer to
remove unbound antibodies. A BD LSRFortessa was used for analysis of rat samples.

Fluorescence activated cell sorting (FACS)
SVCs from P7-14 mice were resuspended in FACS buffer before incubation with
the following antibodies for 30 minutes at 4°C: IL-4Ra-PE (Biolegend, 144803, 1:50);
CD26-FITC (Biolegend, 137806, 1:200); ICAM1-PE/Cy7 (Biolegend, 116122, 1:100),
CD45-APC/Cy7 (Biolegend, 103116, 1:1000), CD31-APC/FIRE (Biolegend, 102528,
1:1000). DAPI (Roche, 10236276001, 1:10000) was added for the final 5 minutes. The
cells were washed with FACS buffer to remove unbound antibodies. Both a BD FACS
Aria cell sorter (BD Biosciences) and a Moflo Astrios EQ (Beckman) using 100 micron
nozzles were used for sorting mouse samples. All compensation was performed at the
time of acquisition using compensation beads (Biolegend, A10497) for single color
staining and SVCs for negative staining and DAPI.
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Rat cell culture and differentiation
SVCs from P3 (control) rat pups were plated at 2x105 cells/well in 48 well plates.
The cells were cultured in DMEM/F12 containing 10% FBS and Primocin (50ng/ml)
(InvivoGen ant-pm-1) for 24 hours to encourage attachment. Cells were treated for
another 48 hours with either 10nM IL-4 or PBS (vehicle) and then counted and analyzed
for beige lineage genes using qRT-PCR.
SVCs from either P3 (control) or 10-week-old (control and IL-4 injected) rats
were also plated at 2x105 cells/well in 48 well plates for differentiation. On day 1 the cells
were cultured in DMEM/F12 containing 10% FBS and Primocin (50ng/ml) (InvivoGen
ant-pm-1) for 24 hours to encourage attachment. On days 2-4, cells received a
pretreatment. On days 4-6 for adipogenic differentiation, cells were cultured in
DMEM/F12 containing 10% FBS and a full adipogenic cocktail of 3.3mU/mL insulin, 1
nM T3, 1uM dexamethasone (Sigma D4902), 0.5 𝜇M isobutylmethylxanthine (Sigma
17018), 125 nM indomethacin (Sigma D8280) and 1 𝜇M rosiglitazone (Sigma R2408).
For days 6-8 cells were cultured in adipocyte maintenance medium of DMEM/F12
containing 10% FBS, 3.3 mU/mL insulin, 1 nM T3, and 1 𝜇M rosiglitazone. Medium was
changed every 2 days and cells harvested between days 8-12 of culture. IL-4 or PBS
(vehicle) was added for different exposure periods during differentiation (Pretreatment,
IL-4 treatment from day 2-4; multi-clonal expansion (MCE), IL-4 treatment from day 46; Terminal differentiation, IL-4 treatment from day 6-8; Throughout, IL-4 treatment
from day 2-8).

Mouse cell culture and differentiation
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SVCs and sorted ICAM1+ preadipocytes from P7-14 mice were plated at 0.751x105 cells/well in 96 well plates. The cells were cultured in DMEM/F12 containing 10%
FBS and Primocin (50ng/ml) (InvivoGen ant-pm-1) for 24 hours to encourage
attachment. Next, cells began differentiation or were treated for another 48 hours with
either 10nM IL-4 or PBS (vehicle) before differentiation. To induce adipogenic
differentiation, cells were cultured for 2 days in DMEM/F12 containing 10% FBS and a
full adipogenic cocktail of 3.3mU/mL insulin, 1 nM T3, 1uM dexamethasone (Sigma
D4902), 0.5 𝜇M isobutylmethylxanthine (Sigma 17018), 125 nM indomethacin (Sigma
D8280) and 1 𝜇M rosiglitazone (Sigma R2408). Cells were also treated with either 10nM
IL-4 or PBS for 48 hours at the beginning of differentiation. Afterwards, cells were
cultured in adipocyte maintenance medium of DMEM/F12 containing 10% FBS, 3.3
mU/mL insulin, 1 nM T3, and 1 𝜇M rosiglitazone. Cells were again treated with either 10
nM IL-4 or PBS for 48 hours. Medium was changed every 2 days and cells harvested at
day 4 of differentiation.

Cell culture imaging
The Biotek Cytation 5 Cell Imaging Multi-Mode Reader was used along with
Gen5 3.04 Imager software to image cell cultures in phase contrast and brightfield at 20x.

Quantitative reverse transcription PCR
Total RNA was isolated from fat depots of rat and mouse pups as well as primary
cell cultures using the RNeasy Mini Kit (Qiagen). RNA was bioanalyzed for RNA
integrity and quantity (Agilent). 1 µg of RNA was reverse transcribed using the iScript
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cDNA synthesis kit and then real-time polymerase chain reaction (14) was performed
using Taqman universal master mix on a Via machine. Taqman probes are listed below
(Table 5.1). Tata-binding protein (Tbp, Rn01455646_m1) was used as a normalization
control. Statistical analyses were carried out using ∆∆Ct values and data was graphed
using 2!∆∆ Ct (fold change of IL-4 treated samples compared to PBS controls).
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Assay ID
Species
Gene
Rat
Tmem26
Rn01428021_m1
Rat
Tnfrsf9
Rn01519016_m1
Rat
Klhl13
Rn01475504_m1
Rat
Rn00440945_m1
Pparg
Rat
Lep
Rn00565158_m1
Rat
Prdm16
Rn01516224_m1
Rat
Ucp1
Rn00562126_m1
Rat
Rn01507024_m1
IL-4R𝛼
Rat
Adipoq
Rn00595250_m1
Rat
Retn
Rn00595224_m1
Rat
Tbp
Rn01455646_m1
Mouse
Adipoq
Mm00456425_m1
Mouse
CD36
Mm00432403_m1
Mouse
Lep
Mm00434759_m1
Mouse
Retn
Mm00445641_m1
Mouse
Prdm16
Mm00712556_m1
Mouse
Ucp1
Mm01244861_m1
Mouse
Tbp
Mm01277042_m1
Table 5.1: List of Taqman probes used in this dissertation
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Bulk RNA sequencing
Total RNA was isolated from iWAT ICAM1+ preadipocytes of P14 mice using
the RNeasy Mini Kit (Qiagen). Poly-A selection was used to isolated mRNA. Strandspecific libraries were generated using the TruSeq Stranded mRNA Library Prep Kit
(Illumina). cDNA libraries were single end sequenced (100bp) on an Illumina NovaSeq
6000. Reads were aligned to the mouse transcriptome (mmGRC39) using STAR and
analyzed for differential expression of genes using DESeq2. Genes with an FDR<0.1 and
an absolute log2FC>0.5. Bioinformatics was done at the Bioinformatics Core of the
Institute for Biomedical Informatics at the University of Pennsylvania.

Statistical methods
All data were analyzed using Prism (Graphpad). Data points were analyzed for
normal distribution using the Shapiro-Wilk test and log transformed if necessary. Power
analysis was used to calculate sample size and we approximated a 25% change with a
standard deviation of 20%, 80% power and a significance level a of 0.05. Nested 1-way
ANOVA was used to exclude litter as a significant variable and data was analyzed using
unpaired 2-tailed student t-tests. All P values are reported with adjustment for multiple
comparisons, if necessary (such as when multiple genes were compared) and a p-value of
< 0.05 was considered to be statistically significant and is presented as * (p < 0.05), ** (p
< 0.01), *** (p < 0.001), or **** (p < 0.0001) (15). Error bars represent the standard
error of the mean (SEM).
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